搜索此博客

2020年10月28日星期三

EOS Med Chem Impurity Stock 20201029-30

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 
Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象,天下往,往而無害,安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China


Human AGPAT1 (1-acyl-sn-glycerol-3-phosphate acyltransferase alpha) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human AGPAT2 (1-acyl-sn-glycerol-3-phosphate acyltransferase beta) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
1,4-Dimethyl-2-(4-phenylbutoxy)benzene, CAS: 500904-64-3, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O.
Fmoc-L-allylglycine, CAS: 146549-21-5, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₄.
Fmoc-L-cyclopropylglycine, CAS: 1212257-18-5, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₄.
CAY10415, CAS: 146062-49-9, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₄S.
Cellooctaose, CAS: 120434-20-0, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₄₁.
Spaglumic Acid, CAS: 3106-85-2, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃O₈.
Human CDIPT (CDP-diacylglycerol--inositol 3-phosphatidyltransferase) ELISA Kit (96T), CAS: /, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human DGAT1(Diacylglycerol O-acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
1,4-Dimethyl-2-[4-(phenyl-d5)butoxy]benzene, CAS: 1346597-96-3, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₅O.
4-(1-Propenyl) Gemfibrozil, CAS: 500904-61-0, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₃.
Fmoc-l-propargylglycine, CAS: 198561-07-8, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₄.
Fmoc-N-(1-Boc-piperidin-4-yl)-glycine, CAS: 269078-80-0, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.
Chicken SLC2A2 (Solute carrier family 2, facilitated glucose transporter member 2) ELISA Kit (96T), CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Chicken UGDH (UDP-glucose 6-dehydrogenase) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Spaglumic Acid-d3, CAS: /, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃N₂O₈.
Human DGKA (Diacylglycerol kinase alpha) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human DGKG (Diacylglycerol kinase gamma) ELISA Kit (96T), CAS: /, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
6’-Propene-1-yl Gemfibrozil, CAS: 1798429-95-4, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₃.
Gemfibrozil, CAS: 25812-30-0, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₃.
Fmoc-n-(butyl)-glycine, CAS: 234442-58-1, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.
Fmoc-n-(tert-butyloxycarbonylethyl)-glycine, CAS: 174799-89-4, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₆.
Chitotetraose Tetrahydrochloride, CAS: 117399-50-5, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₆N₄O₁₇ • 4HCl.
Chitotriose Trihydrochloride, CAS: 117436-78-9, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅N₃O₁₃ • 3HCl.
Thyrotropin-Releasing Hormone, CAS: 24305-27-9, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₆O₄.
Human GK (Glycerol kinase) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human GK2 (Glycerol kinase 2) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Gemfibrozil 1-O-β-D-(3,4,5-O-Triacetyl)glucuronide Methyl Ester, CAS: /, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈O₁₂.
Gemfibrozil 1-O-β-D-Glucuronide Allyl Ester, CAS: /, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₉.
Fmoc-n-(tert-butyloxycarbonylmethyl)-glycine, CAS: 141743-16-0, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₆.
Fmoc-n-[2-(tritylmercapto)ethyl]-glycine, CAS: 882847-27-0, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₃NO₄S.
Chromium Picolinate, CAS: 14639-25-9, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂CrN₃O₆.
Z-L-Glu(ochex)-oh dcha, CAS: 111479-43-7, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅NO₆ •C₁₂H₂₃N.
ZJ 43, CAS: 723331-20-2, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₇.
Human LIPC(Hepatic triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human LIPF(Gastric triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Gemfibrozil 1-O-β-D-Glucuronide Benzyl Ester, CAS: /, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆O₉.
Gemfibrozil 1-O-β-Glucuronide (contains up to 15% α isomer), CAS: 91683-38-4, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₉.
Fmoc-nalpha-methyl-L-phenylglycine, CAS: 574739-36-9, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁NO₄.
Fmoc-phenylalanyl-glycine, CAS: 169624-67-3, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄N₂O₅.
[D-Ala2]-Deltorphin II Trifluoroacetic Acid Salt, CAS: /, stock: 5.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₄N₈O₁₀ • x(C ₂HF₃O₂).
Human LPGAT1 (Acyl-CoA:lysophosphatidylglycerol acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human MGL(Monoacylglycerol Lipase) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Gemfibrozil 1-O-β-Glucuronide-d6, CAS: 1703747-47-0, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄D₆O₉.
Gemfibrozil-d6, CAS: 1184986-45-5, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₆O₃.
Fmoc-Phg-OH, CAS: 102410-65-1, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉NO₄.
Fmoc-Sar-OH, CAS: 77128-70-2, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.
Clinodiside A, CAS: 916347-31-4, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.
Human PGS1 (CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human PGS1(CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Gemfibrozil-d6 1-O-β-D-Glucuronide Benzyl Ester, CAS: /, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀D₆O₉.
iso-Gemfibrozil (Gemfibrozil Impurity), CAS: 86837-66-3, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₃.
Formamidine Hydrochloride, CAS: 6313-33-3, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₅ClN₂.
Cobalt(II) Chloride Hydrate, CAS: 69098-14-2, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₂Co  •xH₂O.
Human PNLIP(Pancreatic triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
α,α’-Dilaurin, CAS: 539-93-5, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₂O₅.
Formiminoglycine, CAS: 06/03/2140, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆N₂O₂.
Formyl-D-phenylglycine, CAS: 10419-71-3, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.
Cytochalasin A, CAS: 14110-64-6, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅NO₅.
α,α’-Dilaurin-d5, CAS: /, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₇D₅O₅.
Fructosyl Glycine α/β Mixture (Mixture of Diastereomers), CAS: 60644-20-4, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₇.
D-(+)-Cellobiose, CAS: 528-50-7, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
α-Glycerophosphoric Acid Dicyclohexylammonium Salt, CAS: 14703-68-5, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₅N₂O₆P.
α-Glycerophosphoric Acid-13C3 Bis-cyclohexylammonium Salt, CAS: 1346602-89-8, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₃H₃₅N₂O₆P.
Gadopentetate Monomeglumine, CAS: 92923-57-4, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇GdN₄O₁₅.
D-(+)-Cellohexose, CAS: 2478-35-5, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₃₁.
D-(+)-Cellopentaose, CAS: 2240-27-9, stock: 9.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂₆.
α-Glycerophosphoric Acid-d5 Dicyclohexylammonium Salt, CAS: /, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀D₅N₂O₆P.
α-Monomyristin, CAS: 589-68-4, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₄O₄.
Gelsemine, CAS: 509-15-9, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂.
D-(+)-Cellotetraose, CAS: 38819-01-1, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
D-(+)-Cellotriose, CAS: 33404-34-1, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆.
α-Monomyristin-d5, CAS: /, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉D₅O₄.
β-Glucosylglycerol 2,3,4,6-Tetraacetate, CAS: 157024-67-4, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆O₁₂.
Glutathione, CAS: 70-18-8, stock: 4.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇N₃O₆S.
Glutathione (glycine-13C2,15N) Sodium Salt, CAS: /, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₇N₂¹⁵NO₆S  •xNa.
D-(+)-Maltose Monohydrate, CAS: 6363-53-7, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄O₁₂.
D-(+)-Maltose Monohydrate-UL-13C12, CAS: /, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₂₄O₁₂.
β-Glycerol Phosphate Disodium Salt Pentahydrate, CAS: 13408-09-8, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₇Na₂O₁₁P.
β-Glycerol-d5 Phosphate Disodium Salt Pentahydrate, CAS: /, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₂D₅Na₂O₁₀P.
Glutathione (glycine-13C2,15N) Trifluoroacetate Salt, CAS: /, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₇N₂¹⁵NO₆S  • C₂HF₃O₂.
Glutathione Ammonium Salt-d5, CAS: /, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₅N₃O₆S (free acid).
D-(+)-Maltose Monohydrate-UL-d14, CAS: /, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₁₄O₁₂.
D-(+)-Maltose-1-13C Monohydrate, CAS: /, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₁₁H₂₄O₁₂.
Glutathione Dimethyl Ester Disulfide Dihydrochloride, CAS: 146963-33-9, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂Cl₂N₆O₁₂S₂.
D-(+)-Raffinose Pentahydrate, CAS: 17629-30-0, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₄₂O₂₁.
D-(+)-Raffinose-13C6, CAS: /, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₆H₃₂O₁₆.
JJKK 048, CAS: 1515855-97-6, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂N₄O₅.
JW 642, CAS: 1416133-89-5, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀F₆N₂O₃.
Glycine, CAS: 56-40-6, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅NO₂.
D-(+)-Raffinose-d6, CAS: /, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆D₆O₁₆.
D-(+)-Trehalose Dihydrate, CAS: 6138-23-4, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁•2H₂O.
KML-29, CAS: 1380424-42-9, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₆NO₇.
Glycine 6-Ethylchenodeoxycholate-d5, CAS: /, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂D₅NO₅.
Glycine Anhydride(2,5-Piperazinedione), CAS: 106-57-0, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂O₂.
D-Altrose, CAS: 1990-29-0, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
D-Altrose-1-13C, CAS: 70849-27-3, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
L-Glycerol 1-Phosphate Lithium Salt, CAS: /, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈LiO₆P.
Glycine Benzyl Ester Hydrochloride, CAS: 2462-31-9, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₂.
Glycine Benzyl Ester p-Toluenesulfonate, CAS: 1738-76-7, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₅S.
D-Altrose-2-13C, CAS: /, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Arabinose, CAS: 28697-53-2, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.
L-Isoleucine Orlistat, CAS: 1072902-75-0, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₃NO₅.
Glycine Benzyl Ester-13C2,15N p-Toluenesulfonate, CAS: 874462-68-7, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₂H₁₉¹⁵NO₅S.
Glycine beta-Naphthylamide, CAS: 716-94-9, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O.
D-Arabinose-1,2-13C2, CAS: /, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀O₅.
D-Arabinose-1,3-13C2, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀O₅.
Lipase AY 30, CAS: 9001-62-1, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.
Glycine beta-Naphthylamide Hydrochloride, CAS: 1208-12-4, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O  •  HCl.
Glycine Ethyl Ester, CAS: 459-73-4, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.
D-Arabinose-1,5-13C2, CAS: /, stock: 4.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀O₅.
D-Arabinose-1-13C, CAS: 70849-23-9, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
Glycine Ethyl Ester Hydrochloride, CAS: 623-33-6, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClNO₂.
Glycine Hydrochloride, CAS: 6000-43-7, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆ClNO₂.
D-Arabinose-1-d, CAS: 77583-92-7, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉DO₅.
D-Arabinose-13C5, CAS: /, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₀O₅.
MEDICA 16, CAS: 87272-20-6, stock: 1.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₈O₄.
Melezitose Monohydrate, CAS: 10030-67-8, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆ [Anhydrous].
Glycine Lauryl Ester Hydrochloride, CAS: 16194-11-9, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₀ClNO₂.
Glycine Methyl Ester Hydrochloride, CAS: 5680-79-5, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈ClNO₂.
D-Arabinose-2,3,4,5-13C4, CAS: /, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₄H₁₀O₅.
D-Arabinose-2-13C, CAS: 101615-87-6, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
Menthone 1,2-Glycerol Ketal, CAS: 67785-70-0, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄O₃.
Methyl cis-11-Eicosenoate, CAS: 02/09/2390, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀O₂.
Glycine N-Ethyl Amide Hydrochloride, CAS: 26595-78-8, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁ClN₂O.
Glycine N-Propyl Ester Hydrochloride, CAS: 13049-01-9, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ • HCl.
D-Arabinose-2-d, CAS: 288846-87-7, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉DO₅.
D-Arabinose-3-13C, CAS: /, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
1-(2’,2’-Difluoro-2’-deoxy-L-erythro-pentofuranos-1-yl)uracil 3’,5’-Di-O-benzoate, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈F₂N₂O₇.
1’,3’-Epi Gemcitabine 3’,5’-Dibenzoate, CAS: 1268237-46-2, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉F₂N₃O₆.
MJN110, CAS: 1438416-21-7, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁Cl₂N₃O₄.
Glycine Sulfate, CAS: 513-29-1, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅NO₂ • 1/3H ₂SO₄.
D-Arabinose-4,5-13C2, CAS: /, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀O₅.
D-Arabinose-5,5’-d, CAS: /, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈DO₅.
1’-Epi 2’,2’-Difluoro-2’-deoxyuridine, CAS: 153381-14-7, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀F₂N₂O₅.
1’-Epi 2’,2’-Difluoro-2’-deoxyuridine 3’,5’-Dibenzoate, CAS: 143157-24-8, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈F₂N₂O₇.
Monodocosahexaenoin, CAS: 140670-40-2, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₄.
Monoerucin, CAS: 28063-42-5, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₈O₄.
Glycine t-Butyl Ester Hydrochloride, CAS: 27532-96-3, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂.
Glycine-13C, CAS: 20220-62-6, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³CH₅NO₂.
D-Arabinose-5-13C, CAS: 139657-60-6, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
D-Cellobiose-1-13C, CAS: /, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₂O₁₁.
1’-Epi Gemcitabine 3’,5’-Dibenzoate, CAS: 134790-40-2, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉F₂N₃O₆.
1’-Epi Gemcitabine Hydrochloride, CAS: 122111-05-1, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClF₂N₃O₄.
Monoerucin-d5, CAS: /, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₃D₅O₄.
Monolaurin, CAS: 142-18-7, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀O₄.
Glycine-13C2, CAS: 67836-01-5, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂H₅NO₂.
Glycine-13C2 Ethyl Ester Hydrochloride, CAS: 1246819-31-7, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₁₀ClNO₂.
D-Cellobiose-13C12, CAS: /, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₂₂O₁₁.
D-Cellobiose-13C6, CAS: /, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₅O₁₁.
1’-Epi Gemcitabine-13C,15N2   3’,5’-Dibenzoate, CAS: /, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₁₉F₂N¹⁵N₂O₆.
1’-Epi Gemcitabine-13C,15N2 Hydrochloride, CAS: /, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂ClF₂N¹⁵N₂O₄.
Monolaurin-d5, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅D₅O₄.
Mouse Abhd12 (Monoacylglycerol lipase ABHD12) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Glycine-13C2,15N, CAS: 211057-02-2, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂H₅¹⁵NO₂.
Glycine-13C2,15N Methyl Ester Hydrochloride, CAS: /, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₂H₇¹⁵NO₂•HCl.
D-Cellobiose-1’-13C, CAS: /, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₂O₁₁.
D-Digitoxose, CAS: 527-52-6, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₄.
2-Deoxy-2,2-difluoro-D-erythro-ribofuranose-3,5-dibenzoate, CAS: 143157-22-6, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆F₂O₆.
2-Deoxy-2,2-difluoro-D-erythro-ribofuranose-3,5-dibenzoate 1-Methanesulfonate, CAS: 122111-11-9, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₂O₈S.
Mouse Agpat1 (1-acyl-sn-glycerol-3-phosphate acyltransferase alpha) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Agpat2 (1-acyl-sn-glycerol-3-phosphate acyltransferase beta) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Glycine-15N, CAS: 7299-33-4, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅¹⁵NO₂.
D-Digitoxose Tribenzoate, CAS: 104652-04-2, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄O₇.
D-Fructose 6-Phosphate-13C6 Disodium Salt, CAS: /, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₁Na₂O₉P.
2-Deoxy-2,2-difluoro-D-threo-furo-pentose-3,5-dibenzoate 1-Methanesulfonate, CAS: /, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₂O₈S.
2’,2’-Difluoro-2’-deoxycytidine, CAS: 103882-84-4, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁F₂N₃O₄.
Mouse Cdipt (CDP-diacylglycerol--inositol 3-phosphatidyltransferase) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse DGAT1(Diacylglycerol O-acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(R)-Ginsenoside Rg2, CAS: 80952-72-3, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₃.
20(R)-Ginsenoside Rg3, CAS: 38243-03-7, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₃.
Glycine-15N,d2, CAS: /, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃D₂¹⁵NO₂.
Glycine-2-13C Ethyl Ester Hydrochloride, CAS: 58420-91-0, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₁₀ClNO₂.
D-Galactose, CAS: 59-23-4, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
D-Galactose-1,2-13C2, CAS: 478518-63-7, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
2’,2’-Difluoro-2’-deoxyuridine, CAS: 114248-23-6, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀F₂N₂O₅.
Mouse Dgka (Diacylglycerol kinase alpha) ELISA Kit (96T), CAS: /, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Dgkg (Diacylglycerol kinase gamma) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(R)-Ginsenoside Rg3-d6, CAS: /, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₆D₆O₁₃.
20(R)-Ginsenoside Rh2, CAS: 112246-15-8, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₈.
Glycine-d2, CAS: 4896-75-7, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃D₂NO₂.
Glycine-d5, CAS: 4896-77-9, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂D₅NO₂.
D-Galactose-1,6-13C2, CAS: 478518-64-8, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Galactose-1-13C, CAS: 70849-30-8, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
2’,2’-Difluoro-2’-deoxyuridine 3’,5’-Dibenzoate, CAS: 143157-27-1, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈F₂N₂O₇.
2’,2’-Difluoro-2’-deoxyuridine-13C,15N2, CAS: 1233921-75-9, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₀F₂¹⁵N₂O₅.
Mouse Gk (Glycerol kinase) ELISA Kit (96T), CAS: /, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gk2 (Glycerol kinase 2) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(R)-Ginsenoside Rh2-d6, CAS: /, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₆D₆O₈.
20(R)-Protopanaxdiol, CAS: 03/01/7755, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₃.
Glycine-n-t-boc (15N, 98%), CAS: 106665-75-2, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃¹⁵NO₄.
Glycinexylidide Hydrochloride, CAS: 35891-83-9, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClN₂O.
D-Galactose-1-d, CAS: 64267-73-8, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
D-Galactose-13C6, CAS: 74134-89-7, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₆.
2’,2’-Difluoro-2’-deoxyuridine-13C2,15N2, CAS: /, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₂H₁₀F₂¹⁵N₂O₅.
2’-​Deoxy-​5’-​O-​[(1,​1-​dimethylethyl)​dimethylsilyl]​-​2’,​2’-​difluorocytidine, CAS: 1151528-36-7, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅F₂N₃O₄Si.
Mouse Gk5 (Putative glycerol kinase 5) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gpd1l (Glycerol-3-phosphate dehydrogenase 1-like protein) ELISA Kit (96T), CAS: /, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(R)​-​Ginsenoside Rh1, CAS: 80952-71-2, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₉.
20(S)-Ginsenoside F1, CAS: 53963-43-2, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₉.
Glycinexylidide-d6 Hydrochloride, CAS: /, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₆ClN₂O.
Glycinexylidide-d6 Hydrochloride, CAS: /, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₆ClN₂O.
D-Galactose-2-13C, CAS: 314062-47-0, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Galactose-2-d, CAS: 64429-86-3, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
2’-Deoxy-2’,2’-difluoro Thymidine, CAS: 95058-80-3, stock: 2.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂F₂N₂O₅.
Mouse Lipf(Gastric triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Lpgat1 (Acyl-CoA:lysophosphatidylglycerol acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(S)-Ginsenoside F2, CAS: 62025-49-4, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₃.
20(S)-Ginsenoside Rg2, CAS: 52286-74-5, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₃.
Glycinexylidine-d6-phthalimide, CAS: /, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₆N₂O₃.
Glycoaldehyde Dimer, CAS: 23147-58-2, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄.
D-Galactose-3,5-d2, CAS: /, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₂H₁₀O₆.
D-Galactose-3-13C, CAS: 478518-56-8, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
2’-Deoxy-2’,2’-difluoro-5,6-dihydro-6-hydroxyuridine (Mixture of Diastereomers), CAS: /, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂F₂N₂O₆.
2’-Deoxy-2’,2’-difluorocytidine 5’-(4-Methylbenzenesulfonate), CAS: 1151528-53-8, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇F₂N₃O₆S.
Mouse Mogat1 (2-acylglycerol O-acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Pgp (Glycerol-3-phosphate phosphatase) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(S)-Ginsenoside Rh2, CAS: 78214-33-2, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₈.
20(S)-Ginsenoside Rh2-d6, CAS: /, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₆D₆O₈.
Glycoaldehyde Dimer-13C4, CAS: /, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₈O₄.
D-Galactose-3-d, CAS: 478518-70-6, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
D-Galactose-3-sulfate potassium salt, CAS: /, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁KO₉S.
2’-Deoxy-3’,5’-di-O-benzoyl-2’,2’-difluorocytidine, CAS: 134790-39-9, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉F₂N₃O₆.
2’-Deoxy-3’,5’-di-O-benzoyl-2’,2’-difluorocytidine-13C,15N2, CAS: 1267650-42-9, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³CH₁₉F₂N¹⁵N₂O₆.
Mouse Pgs1 (CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
20(S)​-​Ginsenoside Rh1, CAS: 63223-86-9, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₉.
20(Z)-Ginsenoside F4, CAS: 126223-28-7, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₀O₁₂.
D-Galactose-4-13C, CAS: 478518-58-0, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Galactose-4-d, CAS: 478518-71-7, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
2’-Deoxy-5’-O-methyl-uridine, CAS: 134785-27-6, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₅.
2’-Deoxy-uridine 3’,5’-Bis(O-phenyl Carbonothioate), CAS: 849104-78-5, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₂O₇S₂.
N-Oxytriacetoneamine Glycerol Ketal, CAS: 150980-90-8, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂NO₄.
N-[(Phenylmethoxy)carbonyl]-L-serine Methyl Ester, CAS: 1676-81-9, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅.
Ginsenoside C-K, CAS: 39262-14-1, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₈.
D-Galactose-5-13C, CAS: 478518-60-4, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
2’-Deoxy-uridine 3’-(O-Phenyl Carbonothioate), CAS: /, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₆S.
2’-Deoxy-uridine 5’-(O-Phenyl Carbonothioate), CAS: /, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₆S.
N-[5-(2-Bromoacetyl)-2-hydroxyphenyl]methanesulfonamide, CAS: 14347-24-1, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₄SBr.
N2-Lauroyl-L-glutamine, CAS: 109570-04-9, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂N₂O₄.
Ginsenoside Rb1, CAS: 41753-43-9, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₂O₂₃.
Ginsenoside Rb2, CAS: 11021-13-9, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₉₀O₂₂.
D-Galactose-5-d, CAS: /, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
D-Galactose-6-13C, CAS: 478518-62-6, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
3-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-difluoro-3-hydroxypropanoic Acid (R)-Ethyl Ester, CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆F₂O₅.
3’-Epi Gemcitabine (Gemcitabine Impurity), CAS: 103882-85-5, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁F₂N₃O₄.
N2-Lauroyl-L-glutamine-d23, CAS: 1795786-88-7, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₂₃N₂O₄.
NF 1819, CAS: 1881244-28-5, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂FN₅O₄.
Ginsenoside Rc, CAS: 11021-14-0, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₉₀O₂₂.
D-Galactose-6-d2, CAS: /, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₂H₁₀O₆.
D-Gentiobiose, CAS: 554-91-6, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
3’-Epi Gemcitabine 3’,5’-Dibenzoate, CAS: 1268237-46-2, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉F₂N₃O₆.
4-Hydroxy-3,4-dihydro-gemcitabine, CAS: /, stock: 4.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃F₂N₃O₅.
O-Amino-glycerol, CAS: 67435-00-1, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀ClNO₃.
Octadecanoyl Isopropylidene Glycerol-d5, CAS: /, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₁D₅O₄.
Ginsenoside Rd, CAS: 52705-93-8, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₁₈.
Ginsenoside Re, CAS: 52286-59-6, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₁₈.
D-Glucitol-1,1’-d2, CAS: /, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂D₂O₆.
D-Glucitol-1,2-13C2, CAS: /, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₄O₆.
5-Bromo-2’-deoxy-2’,2’-difluorouridine, CAS: 132786-35-7, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrF₂N₂O₅.
5-Bromo-2’-deoxy-2’,2’-difluorouridine 5’-O-Acetate, CAS: /, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁BrF₂N₂O₆.
Oleyl Bromide, CAS: 6110-53-8, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅Br.
R-(-)-1,2-Propanediol, CAS: 4254-14-2, stock: 4.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈O₂.
Ginsenoside Rf, CAS: 52286-58-5, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₄.
Ginsenoside Rg1, CAS: 22427-39-0, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₄.
D-Glucitol-1,6-13C2, CAS: /, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₄O₆.
D-Glucitol-1-13C, CAS: 132144-93-5, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
5-O-Acetyl Gemcitabine, CAS: /, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃F₂N₃O₅.
8-​Nonenoic Acid, CAS: 31642-67-8, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₂.
R-59-022 (Diacylglycerol Kinase Inhibitor I), CAS: 93076-89-2, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆FNO₃S.
R-59-022-d5 (Mono-defluoro Ritanserin-d5), CAS: /, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₁D₅FN₃OS.
Ginsenoside Rg2-d3, CAS: /, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₉D₃O₁₃.
Ginsenoside Rg2-d6, CAS: /, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₆D₆O₁₃.
D-Glucitol-13C6, CAS: 121067-66-1, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₄O₆.
D-Glucitol-2-13C, CAS: 287100-73-6, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
CUR 61414, CAS: 334998-36-6, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₂N₄O₅.
Cyanoacetylurea-13C,15N2, CAS: /, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₅N¹⁵N₂O₂.
D-Glucitol-2-d, CAS: 38116-22-2, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃DO₆.
D-Glucitol-3-13C, CAS: /, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
Ginsenoside Rg6, CAS: 147419-93-0, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₀O₁₂.
D-Glucitol-3-d, CAS: /, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃DO₆.
D-Glucitol-4,5,6,6’-d4, CAS: /, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₄O₆.
FRAX 597, CAS: 1286739-19-2, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClN₇OS.
Gemcitabine, CAS: 95058-81-4, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁F₂N₃O₄.
Ginsenoside Rh3, CAS: 105558-26-7, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀O₇.
Ginsenoside Rh4, CAS: 174721-08-5, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀O₈.
D-Glucitol-4,5,6-13C3, CAS: /, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₁₄O₆.
D-Glucitol-4,5-d2, CAS: /, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂D₂O₆.
Ginsenoside Rk1, CAS: 494753-69-4, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₀O₁₂.
Ginsenoside RK2, CAS: 364779-14-6, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀O₇.
D-Glucitol-4,6-13C2, CAS: /, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₄O₆.
Gemcitabine Diphosphate Triethylamine Salt (>90%), CAS: /, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₈F₂N₆O₁₀P₂.
Gemcitabine Hydrochloride, CAS: 122111-03-9, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClF₂N₃O₄.
Ginsenoside Rk3, CAS: 364779-15-7, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀O₈.
Gypenoside XVII, CAS: 80321-69-3, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₁₈.
D-Glucitol-4-d, CAS: /, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃DO₆.
D-Glucitol-5,6-13C2, CAS: /, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₄O₆.
(2S,5R)-2,5-Dimethylmorpholine, CAS: 1639924-58-5, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO.
Gemcitabine Monophosphate, CAS: 116371-67-6, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂F₂N₃O₇P.
Gemcitabine Monophosphate-13C,15N2, CAS: 1233921-81-7, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂F₂N¹⁵N₂O₇P.
Notoginsenoside Fe, CAS: 88105-29-7, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₈₀O₁₇.
Notoginsenoside R1, CAS: 80418-24-2, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₈₀O₁₈.
D-Glucitol-5-d, CAS: /, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃DO₆.
2,2,6,6-d4-Morpholine, CAS: 35530-94-0, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅D₄NO.
Gemcitabine Monophosphate-15N3, CAS: /, stock: 9.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂F₂¹⁵N₃O₇P.
Gemcitabine Triphosphate Ditriethylamine, CAS: /, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₄F₂N₅O₁₃P₃.
Pseudoginsenoside F11, CAS: 69884-00-0, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₁₄.
Glycyl-Glycyl-Glycine, CAS: 556-33-2, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₃O₄.
D-Glucitol-6,6’-d2, CAS: /, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂D₂O₆.
D-Glucitol-6-13C, CAS: /, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
2-Chloro-4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-ol, CAS: /, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀Cl₂FN₃O₂.
Gemcitabine Triphosphate-13C,15N2 Ditriethylamine, CAS: /, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³CH₄₄F₂N₃¹⁵N₂O₁₃P₃.
Gemcitabine-13C,15N2 Hydrochloride, CAS: 1262897-74-4, stock: 10g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³CH₁₂ClF₂N¹⁵N₂O₄.
Glycyl-L-histidyl-L-lysine, CAS: 49557-75-7, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₆O₄.
Glycylglycine ethyl ester hydrochloride, CAS: 2087-41-4, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃ClN₂O₃.
D-Glucitol-d8, CAS: 287962-59-8, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₈O₆.
D-Glucosamine 6-Phosphate Hydrate, CAS: 3616-42-0, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆NO₉P.
3-(3-Chloro-4-fluorophenyl)-7-methoxy-4-oxo-3,4-dihydroquinazolin-6-yl acetate, CAS: /, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClFN₂O₄.
3-Deschloro-3,4-difluoro Gefitinib, CAS: 184475-50-1, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄F₂N₄O₃.
Gemcitabine-13C3,15N2 Hydrochloride, CAS: /, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₃H₁₂ClF₂N¹⁵N₂O₄.
Meisoindigo, CAS: 97207-47-1, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂N₂O₂.
Glycylglycine Hydrochloride, CAS: 13059-60-4, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₃ • (HCl).
Glyphosate Isopropylamine Salt, CAS: 38641-94-0, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉N • (C  ₃H₈NO₅P).
D-Glucosamine Hydrochloride, CAS: 66-84-2, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₅.
D-Glucosamine Sulfate Salt, CAS: 29031-19-4, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₅ .xH₂SO₄.
3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib, CAS: 1603814-04-5, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClFN₄O₃.
3-Deschloro-4-desfluoro-4-chloro-3-fluoro Gefitinib-d3, CAS: /, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₃ClFN₄O₃.
N-​Benzoyl-​2’-​deoxy-​2’,​2’-​difluorocytidine 3’-Benzoate, CAS: 1020657-43-5, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉F₂N₃O₆.
N-​Benzoyl-​2’-​deoxy-​2’,​2’-​difluorocytidine 3’-Benzoate 5’-(4-Methylbenzenesulfonate), CAS: 1151528-38-9, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₅F₂N₃O₈S.
rac 1-O-Trimethylsilyl 3-Chloro-1,2-propanediol, CAS: 1246820-26-7, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅ClO₂Si.
Glyphosate-13C2,15N, CAS: 1185107-63-4, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₂H₈¹⁵NO₅P.
Glyphosate-13C3,15N, CAS: /, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₈¹⁵NO₅P.
D-Glucosamine-1,2-13C2 Hydrochloride, CAS: /, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₄ClNO₅.
D-Glucosamine-13C Hydrochloride, CAS: 84247-63-2, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄ClNO₅.
3-Desmorpholinyl-3-hydroxyethylamino Gefitinib, CAS: 847949-56-8, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClFN₄O₃.
3-Ethenyl-morpholine, CAS: 148860-48-4, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO.
N-​Benzoyl-​2’-​deoxy-​5’-​O-​[(1,​1-​dimethylethyl)​dimethylsilyl]​-​2’,​2’-​difluorocytidine 3’-Benzoate, CAS: 1151528-37-8, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃F₂N₃O₆Si.
N-Carboxybenzyl Gemcitabine, CAS: 138685-83-3, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇F₂N₃O₆.
Glyphosate-C2-d2, CAS: /, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆D₂NO₅P.
Glyphosate-C3-13C, CAS: /, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³CH₈NO₅P.
D-Glucosamine-13C6 6-Phosphate Hydrate, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₆NO₉P.
D-Glucosamine-15N Hydrochloride, CAS: 42927-60-6, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄Cl¹⁵NO₅.
4-(3-Chloropropyl)morpholine, CAS: 7357-67-7, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO.
4-Chloro-3-fluoroaniline, CAS: 367-22-6, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClFN.
rac 1-Oleoyl-2,3-isopropylidieneglycerol, CAS: /, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₄O₄.
Glyphosate-C3-d2, CAS: /, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆D₂NO₅P.
Glyphosine, CAS: 2439-99-8, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁NO₈P₂.
D-Glucosamine-2-13C Hydrochloride, CAS: /, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄ClNO₅.
D-Glucosamine-2-N-Sulfate Sodium Salt, CAS: 38899-05-7, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂NO₈SNa.
4-Defluoro-4-hydroxy Gefitinib, CAS: 847949-50-2, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅ClN₄O₄.
6,7-Dimethoxyquinazoline-4-one, CAS: 13794-72-4, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₃.
rac 1-Oleoyl-2,3-isopropylidieneglycerol-d5, CAS: /, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉D₅O₄.
rac 1-Oleoyl-2-linoleoylglycerol, CAS: 106292-55-1, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₀O₅.
GSK 4112, CAS: 1216744-19-2, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁ClN₂O₄S.
GSK360A, CAS: 931399-19-8, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇FN₂O₅.
D-Glucosamine-6-13C Hydrochloride, CAS: /, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄ClNO₅.
D-Glucose, CAS: 50-99-7, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one, CAS: 199327-61-2, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₄.
BGT 226, CAS: 1245537-68-1, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉F₃N₆O₆.
rac 1-Oleoyl-2-linoleoylglycerol-d5, CAS: /, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₅D₅O₅.
Guanidinoacetic Acid, CAS: 352-97-6, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇N₃O₂.
Guanidinoacetic-13C2 Acid, CAS: 634616-40-3, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₂H₇N₃O₂.
D-Glucose (3-13C, 99%), CAS: 101615-88-7, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Glucose 6-Phosphate Disodium Salt Hydrate, CAS: /, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁Na₂O₉P•xH₂O.
Gefitinib, CAS: 184475-35-2, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClFN₄O₃.
Gefitinib Impurity 13, CAS: /, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClFN₂O₄.
rac 1-Oleoyl-3-linoleoylglycerol, CAS: 104346-53-4, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₀O₅.
H-Gly-nme2 acetate salt, CAS: 200634-33-9, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O₃.
H-Gly-pna, CAS: 1205-88-5, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₃.
D-Glucose 6-Phosphate-13C6 Disodium Salt Hydrate, CAS: /, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₁O₉PNa₂•xH2O.
Gefitinib Impurity 15, CAS: 1608115-59-8, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClFN₃O₄.
Gefitinib Morpholine N-oxide, CAS: 847949-51-3, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClFN₄O₄.
rac 1-Oleoyl-3-linoleoylglycerol-d5, CAS: /, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₅D₅O₅.
Hadacidin, CAS: 689-13-4, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅NO₄.
HBED, CAS: 35369-53-0, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₆ • 2HCl.
D-Glucose Diethyl Mercaptal, CAS: 1941-52-2, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂O₅S₂.
D-Glucose-1,2,3-13C3, CAS: 478529-32-7, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₁₂O₆.
Gefitinib Morpholine N-oxide-d3, CAS: /, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₃ClFN₄O₄.
Gefitinib-d3, CAS: 1173976-40-3, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₃ClFN₄O₃.
Hemiacetorphan, CAS: 124735-06-4, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₄S.
Hexanoyl Glycine, CAS: 24003-67-6, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.
D-Glucose-1,2-13C2, CAS: 261728-61-4, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Glucose-1,6-13C2, CAS: 287100-67-8, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
Gefitinib-d6, CAS: /, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₆ClFN₄O₃.
Hexanoyl Glycine-13C2,15N, CAS: /, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₅¹⁵NO₃.
Hexanoyl-d11 Glycine, CAS: /, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₁₁NO₃.
D-Glucose-1,6-13C2-6-C-d2, CAS: 157171-80-7, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀D₂O₆.
D-Glucose-1-12C (13C depleted at C1), CAS: /, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹²CC₅H₁₂O₆.
Morpholine, CAS: 110-91-8, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO.
N-(3-Morpholinopropyl) Gefitinib, CAS: 1502829-45-9, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇ClFN₅O₄.
Hexyl Methanethiosulfonate, CAS: 53603-16-0, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆O₂S₂.
D-Glucose-1-13C, CAS: 40762-22-9, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Glucose-1-13C-1-C-d, CAS: 201136-45-0, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁DO₆.
N-(3-Morpholinopropyl) Gefitinib-D8, CAS: /, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉D₈ClFN₅O₄.
O-Desmethyl Gefitinib, CAS: 847949-49-9, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClFN₄O₃.
Gentamicin B, CAS: 36889-15-3, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₈N₄O₁₀.
Hippuric Acid-13C6, CAS: 1163160-18-6, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₉NO₃.
D-Glucose-1-13C-2-C-d, CAS: 201417-06-3, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁DO₆.
D-Glucose-1-C-d, CAS: 106032-61-5, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
O-Desmethyl Gefitinib-d6, CAS: /, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₆ClFN₄O₃.
Gentamicin B1 Acetate Salt, CAS: /, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₀N₄O₁₀ • x(C ₂H₄O₂).
Gentamicin C1a Deuterated Pentaacetate Salt, CAS: /, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₉N₅O₇ •C₁₀H₂₀O₁₀.
Homoallylglycine, CAS: 16258-05-2, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.
Homotaurine N,N-Diacetic Acid, CAS: 134152-15-1, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₇S.
D-Glucose-13C,d7, CAS: /, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₅D₇O₆.
D-Glucose-13C6, CAS: /, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₆.
O-Desmorpholinopropyl Gefitinib, CAS: 184475-71-6, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClFN₃O₂.
O-Desmorpholinopropyl-O-methyl-gefitinib, CAS: 153437-78-6, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃ClFN₃O₂.
Gentamicin C1a Pentaacetate Salt, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₉N₅O₁₇.
Gentamicin C2 Pentaacetate Salt (2 : 1 Mixture of C2 and C2a), CAS: /, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₆₁N₅O₁₇.
Human DMGDH (Dimethylglycine dehydrogenase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human DMGDH(Dimethylglycine dehydrogenase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
D-Glucose-13C6, CAS: 110187-42-3, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₆.
D-Glucose-13C6,d7, CAS: 201417-01-8, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₅D₇O₆.
Human GLDC (Glycine dehydrogenase (decarboxylating), mitochondrial) ELISA Kit (96T), CAS: /, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human GLDC(Glycine Dehydrogenase) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
D-Glucose-2,3,4,5,6-13C5, CAS: /, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₅H₁₂O₆.
D-Glucose-2,3-13C2, CAS: /, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
Human GNMT (Glycine N-methyltransferase) ELISA Kit (96T), CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human GNMT(Glycine N-methyltransferase) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
D-Glucose-2,5-13C2, CAS: /, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Glucose-2-12C (13C depleted at C2), CAS: /, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹²CC₅H₁₂O₆.
rac-1,2-Dihexadecylglycerol, CAS: 13071-60-8, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₇₂O₃.
Human PAM (Peptidyl-glycine alpha-amidating monooxygenase) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Hydantoic Acid-13C,15N Ethyl Ester, CAS: 1189492-16-7, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀N¹⁵NO₃.
D-Glucose-2-13C, CAS: 105931-74-6, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Glucose-2-13C-2-C-d, CAS: 83379-46-8, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁DO₆.
rac-1,2-Dipalmitoylglycerol, CAS: 40290-32-2, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₈O₅.
rac-1,2-Dipalmitoylglycerol-d5, CAS: 944709-32-4, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₃D₅O₅.
D-Glucose-3,4-13C2, CAS: 67759-25-5, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Glucose-3,5-d2, CAS: /, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₂O₆.
D-Glucose-3-13C, CAS: 287100-64-5, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Glucose-3-C-d, CAS: 51517-59-0, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
rac-cis-2-(2,4-Dichlorophenyl)-2-methyl-1,3-dioxolane-4-methanol, CAS: 134071-14-0, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂O₃.
Indole-3-butyryl Glycine, CAS: 796072-70-3, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₃.
Indole-3-carboxylic Acid, CAS: 771-50-6, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₂.
D-Glucose-4,5,6,6’-d4, CAS: 478529-49-6, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈D₄O₆.
D-Glucose-4,5,6-13C3, CAS: 478529-47-4, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₁₂O₆.
Rat Abhd12 (Monoacylglycerol lipase ABHD12) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Cdipt (CDP-diacylglycerol--inositol 3-phosphatidyltransferase) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Indole-3-carboxylic Acid-d5, CAS: /, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₅NO₂.
Iodocyclosporin A, CAS: 59865-14-4, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₀IN₁₁O₁₂.
D-Glucose-4,5-13C2, CAS: 478529-31-6, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Glucose-4,5-d2, CAS: 478529-48-5, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₂O₆.
Rat DAG(Diacylglycerol) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Dgka (Diacylglycerol kinase alpha) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
IOX 2, CAS: 931398-72-0, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₅.
D-Glucose-4,6-13C2, CAS: 478529-45-2, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
D-Glucose-4-13C, CAS: 84270-10-0, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
Rat Dgka(Diacylglycerol kinase alpha) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Dgkg (Diacylglycerol kinase gamma) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
D-Glucose-4-C-d, CAS: 56570-89-9, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
D-Glucose-5,6-13C2, CAS: 478529-46-3, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
Rat Gk (Glycerol kinase) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Lipc(Hepatic triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
α-(Diethylamino)benzeneacetic Acid Ethyl Ester, CAS: 6797-70-2, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₂.
α-(Dimethylamino)phenylacetic Acid, CAS: 14758-99-7, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.
D-Glucose-5-13C, CAS: 120388-24-1, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Glucose-5-C-d, CAS: 136864-16-9, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.
Gastrodin, CAS: 62499-27-8, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₇.
Rat Lipf(Gastric triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Pnlip(Pancreatic triacylglycerol lipase) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
α-(Methylenecyclopropyl)glycine (Mixture of Diastereomers), CAS: 09/07/2517, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₂.
α-Amino-4-(Trifluoromethyl)Benzeneacetic Acid, CAS: 142012-65-5, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈F₃NO₂.
D-Glucose-6,6-d2, CAS: 18991-62-3, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀D₂O₆.
D-Glucose-6-13C, CAS: 106032-62-6, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
sn-1,2-Dioctanoylglycerol, CAS: 60514-48-9, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₆O₅.
sn-Glycerol 3-Phosphate Bis(cyclohexylammonium) Salt, CAS: 29849-82-9, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₅N₂O₆P.
α-[(Diethyl-d10)amino]benzeneacetic Acid Ethyl Ester, CAS: 1346597-98-5, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₁₀NO₂.
β-L-Aspartylglycine, CAS: 3790-52-1, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₅.
D-Glucose-6-13C-6-C-d2, CAS: 478529-33-8, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₀D₂O₆.
D-Glucose-6-phosphate Barium Salt, CAS: 58823-95-3, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BaO₉.
β-L-Aspartylglycine-13C2,15N, CAS: /, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₀N¹⁵NO₅.
γ-D-Glutamylglycine, CAS: 6729-55-1, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂O₅.
D-Glucose-6-phosphate Disodium Salt Tetrahydrate, CAS: /, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁Na₂O₉P  •  4H₂O.
D-Glucose-6-phosphate Trisodium Salt, CAS: 53411-70-4, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀Na₃O₁₀P.
Tetrabutylammonium Borohydride, CAS: 33725-74-5, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₆N⁺ + BH₄⁻.
Tetradecanoic Acid (1R)-1-[[[(2-Aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl Ester, CAS: 998-07-2, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₆NO₈P.
L-(+)-2-Phenylglycine, CAS: 2935-35-5, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.
L-(+)-2-Phenylglycine-d5, CAS: 1246820-68-7, stock: 2.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₅NO₂.
D-Glucose-d12, CAS: /, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₁₂O₆.
D-Gulose, CAS: 4205-23-6, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
Tetraethyl Difluoromethylenebisphosphonate, CAS: 78715-58-9, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀F₂O₆P₂.
threo-1-C-Syringylglycerol, CAS: 121748-11-6, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₆.
L-2-Allylglycine Hydrochloride, CAS: 195316-72-4, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂ • (HCl).
D-Gulose-1-13C, CAS: /, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
D-Gulose-2-13C, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
threo-Guaiacylglycerol, CAS: 27391-16-8, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₅.
D-Lactose Anhydrous, CAS: 63-42-3, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
Triacetin, CAS: 102-76-1, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₆.
L-2-Chlorophenylglycine, CAS: 141315-50-6, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.
L-2-Indanylglycine, CAS: 155239-51-3, stock: 9.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.
D-Maltotriose, CAS: 1109-28-0, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆.
D-Maltotriose Peracetate, CAS: 93911-20-7, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₄O₂₇.
Triacetin-d5, CAS: 159510-46-0, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉D₅O₆.
Triacetin-d9, CAS: /, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅D₉O₆.
L-4-Chlorophenylglycine, CAS: 67336-19-0, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.
L-689,560, CAS: 139051-78-8, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅Cl₂N₃O₃.
D-Panose, CAS: 33401-87-5, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆.
Triarachidin, CAS: 620-64-4, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₂₂O₆.
L-701,324, CAS: 142326-59-8, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄ClNO₃.
L-Allylglycine, CAS: 16338-48-0, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂.
Triarachidin-d5, CAS: /, stock: 1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₁₇D₅O₆.
L-Alpha-cyclohexylglycine, CAS: 14328-51-9, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂.
L-Aminobutyric-2,3,3-d3 Acid, CAS: 81339-59-5, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₃NO₂.
L-CCG-I, CAS: 117857-93-9, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₄.
Tricaproin, CAS: 621-70-5, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈O₆.
Tricaproin-d5, CAS: /, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃D₅O₆.
L-Cyclopropylglycine, CAS: 49606-99-7, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂.
L-Cysteinylglycine, CAS: 19246-18-5, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₃S.
Tridocosahexaenoylglycerol, CAS: 124596-98-1, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₉H₉₈O₆.
L-Cysteinylglycine- 13C2 ,15N, CAS: /, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀N¹⁵NO₃S.
Trielaidin, CAS: 537-39-3, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₀₄O₆.
Trielaidin-d5, CAS: /, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₉₉D₅O₆.
L-Homocysteine Thiolactone Hydrochloride, CAS: 31828-68-9, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈ClNOS.
L-Homopropargylglycine, CAS: 98891-36-2, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₂.
Trierucin, CAS: 2752-99-0, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₉H₁₂₈O₆.
Trierucin-d5, CAS: /, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₉H₁₂₃D₅O₆.
L-α-Glutamyl-L-cysteinylglycine Glutathione, CAS: 119290-90-3, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₆O₁₂S₂.
L-γ-Glutamyl-L-cysteinyl Glutathione, CAS: 90663-73-3, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉N₅O₁₁S₂.
Triglycerol Monolaurate, CAS: 244139-90-0, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₂O₈.
L-Leucyl-glycyl-glycine, CAS: 1187-50-4, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉N₃O₄.
Triglycerol Monostearate, CAS: 150616-94-7, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₄O₈.
L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-glycine, CAS: /, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₁₃N₁₁O₁₄.
D-Threose (~0.4 M aqueous solution), CAS: 95-43-2, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄.
L-Phenylglycine Amide, CAS: 6485-52-5, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O.
D-Threose-13C, CAS: 70849-20-6, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₃H₈O₄.
D-Threose-2-13C, CAS: 478506-49-9, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₃H₈O₄.
Trilaurin, CAS: 538-24-9, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₇₄O₆.
Trilaurin-d5, CAS: /, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₉D₅O₆.
L-tert-Leucine Methyl Ester Hydrochloride, CAS: 63038-27-7, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.
D-Threose-4-13C, CAS: 90913-09-0, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₃H₈O₄.
D-[UL-13C6]Glucosamine Hydrochloride, CAS: /, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₄ClNO₅.
Trilinolenin, CAS: 14465-68-0, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₉₂O₆.
Trilinolenin-d5, CAS: /, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₈₇D₅O₆.
L-Valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-glycine Methyl Ester, CAS: 156047-45-9, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₁₀₄N₁₀O₁₃.
Larazotide Acetate (> 90%), CAS: 881851-50-9, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₉N₉O₁₂.
Dapagliflozin, CAS: 461432-26-8, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₆.
Dapagliflozin 2-O-β-D-Glucuronide, CAS: /, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃ClO₁₂.
Trimyristin, CAS: 555-45-3, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₈₆O₆.
Trimyristin-d5, CAS: /, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₈₁D₅O₆.
Lauroylsarcosine Sodium Salt, CAS: 137-16-6, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈NNaO₃.
Dapagliflozin 3-O-β-D-Glucuronide, CAS: 1351438-75-9, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃ClO₁₂.
Dapagliflozin 3-O-β-D-Glucuronide-d5, CAS: /, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₅ClO₁₂.
Trinonanoin, CAS: 126-53-4, stock: 7.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₆O₆.
Trinonanoin-d5, CAS: /, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₁D₅O₆.
Lauryl Betaine, CAS: 683-10-3, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₃NO₂.
LEI-106, CAS: 1620582-23-1, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇NO₆S.
Dapagliflozin C2 Epimer, CAS: 2133407-75-5, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₆.
Dapagliflozin Dimer, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₈Cl₂O₁₂.
Leukotriene C4-d5, CAS: 1441421-73-3, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂D₅N₃O₉S.
Liraglutide, CAS: 204656-20-2, stock: 3.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇₂H₂₆₅N₄₃O₅₁.
Dapagliflozin Hydroxy Impurity, CAS: 960404-86-8, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₇.
Dapagliflozin Keto Impurity, CAS: 2169998-23-4, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClO₇.
Tripentadecanoin, CAS: 7370-46-9, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₉₂O₆.
Tripentadecanoin-d5, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₇D₅O₆.
Dapagliflozin Tetraacetate, CAS: 461432-25-7, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃ClO₁₀.
Dapagliflozin-D5, CAS: 1204219-80-6, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₅ClO₆.
Tristearin, CAS: 555-43-1, stock: 5.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₁₀O₆.
Tristearin-d5, CAS: /, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₀₅D₅O₆.
LTD4 (Leukotriene D4), CAS: 73836-78-9, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀N₂O₆S.
LY 2365109 Hydrochloride, CAS: 1779796-27-8, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₅ • (HCl).
Dapagliflozin-d5 Tetraacetate, CAS: /, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈D₅ClO₁₀.
De-α-D-glucopyranoside Canagliflozin, CAS: /, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅FS.
Tri[(16-hydroxy)oleoyl]glycerol, CAS: 1346606-52-7, stock: 1.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₁₀₄O₉.
Tri[(16-hydroxy)oleoyl]glycerol-d5, CAS: /, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₉₉D₅O₉.
LY 367385, CAS: 198419-91-9, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.
m-Chloro Hippuric Acid, CAS: 57728-59-3, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈ClNO₃.
De-α-D-glucopyranoside Hydroxy Canagliflozin, CAS: /, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅FOS.
m-Chloro Hippuric Acid-d2,15N, CAS: /, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₂Cl¹⁵NO₃.
Defluoro-Canagliflozin, CAS: 842133-16-8, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆O₅S.
[5-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-1,1-difluoropentyl]-phosphonic Acid, CAS: 130434-88-7, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄F₂N₅O₄P.
Deschloro Dapagliflozin, CAS: /, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₆.
Dextran (Technical Grade~ 100K), CAS: 9004-54-0, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
m-Toluoyl-d7 Chloride, CAS: 1796602-13-5, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈D₇ClO.
Maleimidoacetic Acid, CAS: 25021-08-3, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₄.
Dextran (Technical Grade~ 10K), CAS: 9004-54-0, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Dextran (Technical Grade~ 150K), CAS: 9004-54-0, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
MAPTAM, CAS: 147504-94-7, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄N₂O₁₈.
MDL 29913, CAS: 135721-56-1, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₆N₈O₆.
Dextran (Technical Grade~ 20K), CAS: 9004-54-0, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Dextran (Technical Grade~ 4K), CAS: 9004-54-0, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Mebrofenin, CAS: 78266-06-5, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉BrNO₂N₅.
Melagatran, CAS: 159776-70-2, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁N₅O₄.
Dextran (Technical Grade~ 500K), CAS: 9004-54-0, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Dextran (Technical Grade~ 50K), CAS: 9004-54-0, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Melagatran-d11, CAS: /, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₁₁N₅O₄.
Dextran (Technical Grade~ 60K), CAS: 9004-54-0, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Dextran (~50K), CAS: 9004-54-0, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H(C₆H₁₀O₅)ₓOH.
Memantine Glycine, CAS: 1340545-88-1, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₂.
Memantine Glycine tert-Butyl Ester, CAS: 1537550-23-4, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₂.
Methenamine Hippurate, CAS: 5714-73-8, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₅O₃.
Diethyl Itaconate-13C5, CAS: /, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₄O₄.
Empagliflozin R/S-Furanose, CAS: /, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClO₇.
Ent-α-C Dapagliflozin (Dapagliflozin Impurity), CAS: /, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₆.
Methyl 4-Hydroxy-7-phenoxyisoquinoline-3-carboxylate, CAS: 1455091-10-7, stock: 2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃NO₄.
epi-Canagliflozin, CAS: 1589590-87-3, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FO₅S.
Methyl 4-Methylpyrrole-2-carboxylate, CAS: 34402-78-3, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₂.
Ethyl 1-Bromocyclobutanecarboxylate, CAS: 35120-18-4, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁BrO₂.
Methyl Glyphosate, CAS: 24569-83-3, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₅P.
Methyl N-(4-Hydroxyphenyl)-N-phenylglycinate, CAS: 75110-91-7, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₃.
Methyl N-(4-Hydroxyphenyl)-N-phenylglycinate-d5, CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅NO₃.
Fagomine, CAS: 53185-12-9, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.
Fagomine-13C,d2, CAS: /, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₁D₂NO₃.
Methyl N-Acetylglycinate, CAS: 1117-77-7, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₃.
Fasentin, CAS: 392721-37-8, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉ClF₃NO₂.
Methylglycinediacetic acid-13C2 (MGDA), CAS: 500692-90-0, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₈NNa₃O₆.
Methylthymol Blue Sodium Salt, CAS: 1945-77-3, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₀N₂Na₄O₁₃S.
Flavine Adenine Dinucleotide Disodium Salt, CAS: 84366-81-4, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁N₉Na₂O₁₅P₂.
Flavine Adenine Dinucleotide-13C5 Ammonium Salt, CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₅H₃₃N₉O₁₅P₂ xNH₃.
Methylxylenol Blue, CAS: 29412-85-9, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂N₂Na₄O₁₃S.
Fluoro 2-Deoxy-2-fluoro-3,4,6-tri-O-acetyl-D-glucose, CAS: 86786-39-2, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆F₂O₇.
fluoro-Dapagliflozin, CAS: 1181681-43-5, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClFO₅.
Mouse Dmgdh (Dimethylglycine dehydrogenase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gatm (Glycine amidinotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Fluoroacetic Acid, CAS: 144-49-0, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃FO₂.
2-Acetamido-2-deoxy-3-O-(α-D-galactopyranosyl)-D-galactose, CAS: 60283-31-0, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₁₁.
Mouse Gcsh (Glycine cleavage system H protein, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gldc (Glycine dehydrogenase (decarboxylating), mitochondrial) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Fungitetraose, CAS: 13133-07-8, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
GB1-Cyanine 3, CAS: 1065004-53-6, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₃N₄O₉.
2-Acetamido-2-deoxy-3-O-(β-D-galactopyranosyl)-D-galactose, CAS: 3554-90-3, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₁₁.
2-O-Methyl-α-neuraminic Acid, CAS: 57344-93-1, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₈.
Mouse Glyat (Glycine N-acyltransferase) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gnmt (Glycine N-methyltransferase) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
GFT-505, CAS: 923978-27-2, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄O₄S.
Ginsenoside Rb3, CAS: 68406-26-8, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₉₀O₂₂.
4-Methoxyphenyl 3-O-Allyl-β-D-galactopyranoside, CAS: 144985-19-3, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₇.
5-Bromo-4-chloro-3-indolyl-α-D-N-acetylneuraminic Acid, Methyl Ester, CAS: /, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄BrClN₂O₉.
Mouse Pam (Peptidyl-glycine alpha-amidating monooxygenase) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
MPPG, CAS: 169209-65-8, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂NO₅P.
Glucagon Trifluoroacetic Acid Salt, CAS: /, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅₃H₂₂₅N₄₃O₄₉S  .  x(C₂HF₃O₂).
Glucagon-d9 Trifluoroacetate, CAS: /, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅₃H₂₁₆D₉N₄₃O₄₉S (C ₂HF₃O₂)ₓ.
5-Bromo-4-chloro-3-indolyl-α-D-N-acetylneuraminic Acid, Sodium Salt, CAS: 160369-85-7, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁BrClN₂NaO₉.
C8-Sphingosine, CAS: 133094-50-5, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.
Muraglitazar, CAS: 331741-94-7, stock: 1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈N₂O₇.
Muraglitazar Acyl-β-D-glucuronide, CAS: 875430-26-5, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆N₂O₁₃.
Glucosamine, CAS: 3416-24-8, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₅.
Glucose Pentasulfate, Potassium Salt, Technical Grade, CAS: 359435-44-2, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇O₂₁S₅K₅.
Galacto-PUGNAc, CAS: 1145878-98-3, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₇.
Ganglioside GD1a Disodium Salt, CAS: 12707-58-3, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₄H₁₄₈N₄O₃₉ • x(Na).
N,N,N-Trimethylglycine N-Hydroxysuccinimide Ester Bromide, CAS: 42014-55-1, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅BrN₂O₄.
N,N,N-Trimethylglycine-d9 N-Hydroxysuccinimide Ester Bromide, CAS: /, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₉BrN₂O₄.
Glucose-1-phosphate Dipotassium Salt, CAS: 6736-77-2, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁K₂O₉P.
Glucose-1-phosphate Disodium Salt, CAS: 56401-20-8, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁O₉PNa₂.
Ganglioside GD1b Disodium Salt (Bovine Brain), CAS: 19553-76-5, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₄H₁₄₆N₄Na₂O₃₉.
N,N-Bis[2-(octylamino)ethyl]glycine, CAS: 17670-95-0, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₇N₃O₂.
N,N-Dibenzylglycine Ethyl Ester, CAS: 77385-90-1, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₂.
GM1 Pentasaccharide Sodium Salt, CAS: /, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈N₂O₂₆ • Na.
Guangxitoxin 1E, CAS: 1233152-82-3, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇₈H₂₄₈N₄₄O₄₅S₇.
N,N-Diethylglycine Methyl Ester, CAS: 30280-35-4, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.
N,N-Dimethyl-d6-glycine Hydrochloride, CAS: 347840-03-3, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₆ClNO₂.
GW9508, CAS: 885101-89-3, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁NO₃.
Ganglioside GM1, Asialo, CAS: 71012-19-6, stock: 2.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₂H₁₁₇N₃O₂₃.
Ganglioside GM2, Asialo, CAS: 35960-33-9, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C56H104N2O18.
N,N-Dimethylglycine, CAS: 1118-68-9, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.
N,N-Dimethylglycine Ethyl Ester, CAS: 33229-89-9, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.
Heparin Disaccharide II-S Trisodium Salt, CAS: 136098-05-0, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NNa₃O₁₆S₂.
Heptasaccharide Glc4Xyl3, CAS: 121591-98-8, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆O₃₃.
Ganglioside GQ1b Tetrasodium Salt (Bovine Brain), CAS: 68652-37-9, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀₆H₁₇₈N₆Na₄O₅₅.
Ganglioside GT1b trisodium salt, CAS: 59247-13-1, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉₅H₁₆₂N₅Na₃O₄₇.
N,N-Dimethylglycine hydrazide DiHCl, CAS: 5787-71-3, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₃Cl₂N₃O.
N,N-Dimethylglycine Hydrochloride, CAS: 07/06/2491, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂ • HCl.
Human G6PD(Glucose-6-phosphate 1-dehydrogenase) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human Anti-GM1(Anti-Ganglioside M1 Antibody) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N,N-Dimethylglycine methyl ester, CAS: 03/06/7148, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.
Human GFOD1 (Glucose-fructose oxidoreductase domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Methyl 5-Acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-D-galacto-2-nonulopyranosylonate, CAS: 155155-64-9, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃NO₁₂S.
N,N-Dimethylglycine Methyl Ester Hydrochloride, CAS: 1954-58-1, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ • HCl.
N,N-Dinitroso-p-phenylenediamine-N,N-diacetic Acid, CAS: 6645-64-3, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₄O₆.
Human Glucose ELISA Kit (96T), CAS: /, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human GLUT2(Glucose Transporter 2) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Acetyl-9-O-(N-acetyl-β-neuraminosyl)-neuraminic Acid, CAS: 114608-45-6, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆N₂O₁₇.
N,N-Dinitroso-p-phenylenediamine-N,N-diacetic Acid Dimethyl Ester, CAS: 210835-70-4, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₆.
N,N’-(N,N’-Dicarboxy-L-cystyl)di-glycine Dibenzyl N,N’-Di-tert-butyl Ester, CAS: 32381-30-9, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₆N₄O₁₀S₂.
Human GLUT4(Glucose Transporter 4) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human GOD(Glucose Oxidase) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Acetylneuraminic Acid Dimer Disodium Salt, CAS: 149331-75-9, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄N₂Na₂O₁₇.
N,N’-1,2-Ethanediylbis[N-(carboxymethyl)-glycine Tetrasodium Salt Hydrate, CAS: 194491-31-1, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂Na₄O₈ xH₂O.
N,N’-1,4-Phenylenebis-glycine Dimethyl Ester, CAS: 109025-99-2, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₄.
Human GPI(Glucose 6 Phosphate Isomerase) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human HSPA5(78 kDa glucose-regulated protein) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N,N’-1,4-Phenylenedi-glycine, CAS: 10097-07-1, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.
N,N’-Bisboc N,N’-L-Cystinyldiglycine-13C4,15N2 Dibenzyl Ester, CAS: /, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀¹³C₄H₄₆N₂¹⁵N₂O₁₀S₂.
Human Mortalin(75 kDa glucose-regulated protein) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human SLC2A1(Solute carrier family 2, facilitated glucose transporter member 1) ELISA Kit (96T), CAS: /, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N,N’-Diacetyl-N,N’-1,4-Phenylenedi-glycine Diethyl Ester, CAS: 189194-00-1, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₆.
N,N’-[(1R)-1-(Hydroxymethyl)-1,2-ethanediyl]bis[N-[2-(1,1-dimethylethoxy)-2-oxoethyl]glycine Bis(1,1-dimethylethyl) Ester, CAS: 782480-31-3, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₀N₂O₉.
Human SLC2A2 (Solute carrier family 2, facilitated glucose transporter member 2) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Human SLC2A3(Solute carrier family 2, facilitated glucose transporter member 3) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-(1,1-Dioxido-2,3-dihydro-3-thienyl)glycine, CAS: 201990-24-1, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₄S.
N-(1,1-Dioxidotetrahydro-3-thienyl)-N-methylglycine, CAS: 51070-58-7, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄S.
Human SLC2A8 (Solute carrier family 2, facilitated glucose transporter member 8) ELISA Kit (96T), CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Hydroxypropanedial, CAS: 497-15-4, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄O₃.
N-(1-Oxoheptyl)glycine Ethyl Ester, CAS: 574010-47-2, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₃.
N-(1-Thioxoethyl)glycine, CAS: 412307-34-7, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₂S.
Insulin (Human), CAS: 11061-68-0, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅₇H₃₈₃N₆₅O₇₇S₆.
Ipragliflozin, CAS: 761423-87-4, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁FO₅S.
N-(1H-pyrrol-2-ylcarbonyl)-Glycine, CAS: 98276-81-4, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.
N-(2,3,4,5-Tetrahydro-3,5-dioxo-1,2,4-triazin-6-yl)Glycine [(3,4-dimethoxyphenyl)methylene]hydrazide, CAS: 301679-74-3, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₆O₅.
Ipragliflozin-d5, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₅FO₅S.
Isolevoglucosenone, CAS: 307991-08-8, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.
N-(2,4-Dinitrophenyl)glycine, CAS: 1084-76-0, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₆.
N-(2,5-Dichlorobenzoyl)glycine, CAS: 667403-46-5, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇Cl₂NO₃.
Isomaltopentaose, CAS: 6082-32-2, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂₆.
Isomaltose, CAS: 499-40-1, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
N-(2,6-Diisopropylphenylcarbamoylmethyl)iminodiacetic Acid, CAS: 65717-97-7, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₅.
N-(2-Amino-2-oxoethyl)-N-[(1S)-2-(3,5-dioxo-1-piperazinyl)-1-methylethyl]-glycine, CAS: 120418-77-1, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₄O₅.
Isomaltose-13C, CAS: /, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₂O₁₁.
Isomaltotetraose, CAS: 35997-20-7, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
N-(2-Amino-2-oxoethyl)-N-[(1S)-2-(3,5-dioxo-1-piperazinyl)-1-methylethyl]-glycine + N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)-1-propyl]-glycine (Mixture of Isomers), CAS: /, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₄O₅.
N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]-glycine, CAS: 120418-76-0, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₄O₅.
Isomaltotriose, CAS: 3371-50-4, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆.
N-(2-Aminoethyl)glycine, CAS: 24123-14-6, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₂O₂.
N-(2-Benzoylmercaptopropionyl)glycine-d3 Ethyl Ester, CAS: 1189930-99-1, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₃NO₄S.
Isosteviol, CAS: 27975-19-5, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₃.
N-(2-Carboxyphenyl)glycine, CAS: 612-42-0, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₄.
N-(2-Chloro-1-oxopropyl)glycine, CAS: 85038-45-5, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈ClNO₃.
N-(2-Chlorophenyl)glycine, CAS: 6961-49-5, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.
α,α-[1,1’-D2]Trehalose, CAS: /, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂D₂H₂₀O₁₁.
α,α-[UL-13C12]Trehalose, CAS: /, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₂₂O₁₁.
N-(2-Cyanoethyl)glycine, CAS: 3088-42-4, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₂.
N-(2-Cyanoethyl)glycine Ethyl Ester Hydrochloride, CAS: 1081523-75-2, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂O₂ • HCl.
α,α-[UL-D14]Trehalose, CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂D₁₄H₈O₁₁.
α-​D-​Glucopyranose, CAS: 492-62-6, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
N-(2-Fluorobenzyl)-N-methylglycine Hydrochloride, CAS: 1185301-48-7, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₂F • HCl.
N-(2-Furoyl)glycine Methyl Ester, CAS: 13290-00-1, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₄.
α-Chloralose, CAS: 15879-93-3, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁O₆Cl₃.
α-D-1,5-Difluoroglucose, CAS: 173349-22-9, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀F₂O₅.
N-(2-Furoyl)glycine Methyl Ester-D3, CAS: /, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₃NO₄.
N-(2-Hydroxy-1,1-dimethylethyl)glycine, CAS: 1154902-47-2, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.
α-D-Galactose, CAS: 3646-73-9, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
α-D-Glucose 1,6-Bisphosphate Tetrapotassium Salt, CAS: 91183-87-8, stock: 10g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀K₄O₁₂P₂.
N-(2-Hydroxyethyl)glycine (~90%), CAS: 5835-28-9, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.
N-(2-Hydroxyethyl)iminodiacetic Acid, CAS: 93-62-9, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₅.
α-D-Glucose 1-Phosphate Dipotassium Salt Hydrate, CAS: 1233690-06-6, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃K₂O₉P. (H₂O)ₓ.
α-D-Glucose 1-Phosphate Disodium Salt Tetrahydrate, CAS: /, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁Na₂O₉P  • 4(H ₂O).
N-(2-nitrobenzoyl)glycine, CAS: 10167-23-4, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₅.
N-(2-Pyridylmethyl)glycine Ethyl Ester, CAS: 62402-24-8, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.
α-D-Glucose Pentaacetate, CAS: 604-68-2, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₁.
α-D-Glucose-1,6-biphosphate Tetra(cyclohexylammonium) Salt Hydrate, CAS: /, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₁₂P₂ • 4C ₆H₁₃N  • x( H₂O).
N-(3,4,5,6-Tetrahydro-2-pyridinyl)glycine, CAS: 13754-02-4, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂O₂.
N-(3,4-Dihydro-2H-pyrrol-5-yl)glycine, CAS: 113561-30-1, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀N₂O₂.
α-L-Galactopyranosyl 1-Phosphate Dipotassium Salt, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁K₂O₉P.
N-(3-Acetylthio-2-methylpropanoyl)glycine tert-Butyl Ester, CAS: 1076198-75-8, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₄S.
N-(3-Acetylthio-2-methylpropanoyl)glycine tert-Butyl Ester-d5, CAS: 1190018-72-4, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆D₅NO₄S.
β-D-Galactose, CAS: 7296-64-2, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
β-D-Glucopyranosyl Azide 2,3,4,6-Tetraacetate, CAS: 13992-25-1, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₉.
N-(3-Bromophenyl)glycine, CAS: 42288-20-0, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₄S₃.
β-D-Glucose Pentaacetate, CAS: 604-69-3, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₁.
β-Glucogallin, CAS: 13405-60-2, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₁₀.
N-(3-Indolylacetyl)glycine, CAS: 13113-08-1, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₃.
N-(3-Indolylacetyl)glycine-13C2 ,15N, CAS: /, stock: 2.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₂H₁₂N¹⁵NO₃.
β-Hydroxyparaconic Acid, CAS: 19014-10-9, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₅.
N-(3-Mercapto-2-methylpropanoyl)glycine, CAS: 89021-98-7, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃S.
N-(3-Mercapto-2-methylpropanoyl)glycine-d5, CAS: 1184993-97-2, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₅NO₃S.
β-L-Glucose Pentaacetate, CAS: 66966-07-2, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₁.
β-Nicotinamide Mononucleotide, CAS: 1094-61-7, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₂O₈P.
N-(3-Methoxybenzyl)glycine, CAS: 756754-04-8, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.
β-Nicotinamide Mononucleotide-13C5, CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₅H₁₅N₂O₈P.
β-Nicotinamide-d4 Mononucleotide (d4-major), CAS: /, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₄N₂O₈P.
N-(4-Cyanophenyl)-glycine, CAS: 42288-26-6, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂.
β-Pinene, CAS: 127-91-3, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆.
Kanosamine Hydrochloride, CAS: 57649-10-2, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₅.
(R)-((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)methyl acetate, CAS: /, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₅.
N-(4-Cyanophenyl)-glycine-13C6, CAS: 1919877-35-2, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₈N₂O₂.
N-(4-Fluorobenzyl)-N-methylglycine Hydrochloride, CAS: 1185299-93-7, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₂F • HCl.
Kauniolide, CAS: 81066-45-7, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₂.
Kojibiose, CAS: 2140-29-6, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
(R)-N-(9-(((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)methyl)-6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide mixture with (S)-N-(7-(((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)methyl)-6-oxo-6,7-dihydro-1H-purin-2-yl)acetamide, CAS: /, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₅O₅.
(R,S)-Iso Valganciclovir, CAS: 1356932-18-7, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₆O₅.
N-(4-Fluorophenyl)glycine, CAS: 351-95-1, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₂F.
N-(4-Hydroxyphenyl)-N-phenylglycine, CAS: /, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.
L-(−)-Chiro-Inositol, CAS: 551-72-4, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
(S)-((1-(Benzyloxy)-3-((4-methoxyphenyl)diphenylmethoxy)propan-2-yl)oxy)(tert-butyl)dimethylsilane, CAS: /, stock: 4.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₄O₄Si.
(S)-1-[(4-Methoxyphenyl)diphenylmethoxy]-3-(phenylmethoxy)-2-propanol, CAS: 120362-27-8, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀O₄.
N-(4-Hydroxyphenyl)-N-phenylglycine-d5, CAS: /, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₅NO₃.
N-(4-Methylphenyl)-N-(methylsulfonyl)glycine, CAS: 425616-93-9, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₄S.
(S,R)-Iso Valganciclovir, CAS: 1356932-18-7, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₆O₅.
(S,S)-Iso Valganciclovir Hydrochloride, CAS: 1401562-13-7, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₆O₅.
N-(5-(4-Cyanophenyl)-3-hydroxypicolinoyl)glycine, CAS: /, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁N₃O₄.
N-(5-Bromo-2-methylphenyl)glycine, CAS: 66947-36-2, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.
(S,S)-Iso Valganciclovir Hydrochloride-d8, CAS: /, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅D₈ClN₆O₅.
(T-4)-Triphenyl(P,P,P-triphenylphosphine imidato-κN)-phosphorus Diphosphate, CAS: 1927003-40-4, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀NP₂⁺ •  H₄O₇P₂.
N-(5-Formylpyrimidin-2-yl)glycine, CAS: 915923-65-8, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₃O₃.
N-(6-Methoxy-3-pyridinyl)-N-[(2-methylphenyl)sulfonyl]glycine, CAS: 680591-44-0, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₅S.
N-(Benzyloxycarbonyl)aminodiacetic Acid, CAS: 17335-88-5, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₆.
1,9-Dihydro-9-[[1-[[(4-methoxyphenyl)diphenylmethoxy]methyl]-2-(phosphonooxy)ethoxy]methyl]-2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6H-purin-6-one, CAS: 91516-86-8, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₆N₅O₉P.
N-(Carboxymethyl)-N-(phosphonomethyl)-glycine, CAS: 5994-61-6, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀NO₇P.
L-Galactose, CAS: 15572-79-9, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
1,9-Dihydro-9-[[2-hydroxy-1-[[(4-methoxyphenyl)diphenylmethoxy]methyl]ethoxy]methyl]-2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6H-purin-6-one, CAS: 88110-86-5, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₅N₅O₆.
1,9-Dihydro-9-[[2-hydroxy-1-[[(4-methoxyphenyl)diphenylmethoxy]methyl]ethoxy]methyl]-2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6H-purin-6-one Triphosphate Tributylamine, CAS: /, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₈N₅O₁₅P₃ • x( C₁₂H₂₇N).
N-(Carboxymethyl)amphetamine Hydrochloride, CAS: 60342-93-0, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂•HCl.
L-Galactose-13C6, CAS: 478518-66-0, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₂O₆.
L-Galactose-3-13C, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
2-Amino-1,7-dihydro-7-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one, CAS: 84222-50-4, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₄.
N-(Chloroacetyl)glycine Ethyl Ester, CAS: 41602-50-0, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀NO₃Cl.
N-(Cyclopropylsulfonyl)glycine, CAS: 1203136-68-8, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄S.
L-Glucitol, CAS: 6706-59-8, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₆.
L-Glucitol-1-13C, CAS: /, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
2’-Monodehydroxy-2’-chloro Ganciclovir, CAS: 108436-36-8, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN₅O₃.
2’-Monodehydroxy-2’-chloro Ganciclovir-d5, CAS: /, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₅ClN₅O₃.
N-(Diphenylmethylene)glycine Benzyl Ester, CAS: 81477-91-0, stock: 3.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉NO₂.
N-(Diphenylmethylene)glycine Ethyl Ester, CAS: 69555-14-2, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.
L-Glucitol-2-13C, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₄O₆.
L-Glucose, CAS: 921-60-8, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
N-(Diphenylmethylene)glycine tert-butyl ester, CAS: 81477-94-3, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂.
L-Glucose-1,2,3-13C3, CAS: /, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₁₂O₆.
L-Glucose-1,2-13C2, CAS: /, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₂O₆.
9-[[2-Chloroprop-2-en-1-yl)oxy]methyl]guanine, CAS: 1797982-93-4, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClN₅O₂.
N-(Diphenylmethylene)glycine, t-Butyl Ester, CAS: 81477-94-3, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂.
N-(Dithiocarboxy)sarcosine Diammonium Salt, CAS: 29664-09-3, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₃N₃O₂S₂.
L-Glucose-1-13C, CAS: 478519-02-7, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
L-Glucose-2-13C, CAS: 478519-05-0, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
Chloromethyl Acetate, CAS: 625-56-9, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅ClO₂.
N-(Methoxycarbonyl)glycine, CAS: 1670-97-9, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₄.
L-Glucose-3-13C, CAS: /, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₁₂O₆.
Chloromethylphosphonic Dichloride, CAS: 1983-26-2, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₂Cl₃OP.
D-Valganciclovir Hydrochloride, CAS: 1393911-57-3, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₆O₅.
N-(Perfluoro-1-octanesulfonyl) Glycine, CAS: 2806-24-8, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄F₁₇NO₄S.
N-(Phenylacetyl-d5)glycine, CAS: 1189920-31-7, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₅NO₃.
L-Leucine Methyl Ester Hydrochloride, CAS: 7517-19-3, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.
L-Leucine tert-Butyl Ester Hydrochloride, CAS: 09/02/2748, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂ClNO₂.
D-Valganciclovir-d5 Hydrochloride, CAS: /, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₅ClN₆O₅.
Dedihydroxy Dichloroganciclovir, CAS: 441349-85-5, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁Cl₂N₅O₂.
N-(Phenylmethoxy)glycine Phenylmethyl Ester, CAS: 366792-97-4, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₃.
N-(Phenylsulfonyl)glycine Methyl Ester, CAS: 69398-48-7, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄S.
Dedihydroxy N-Acetyl-dichloroganciclovir, CAS: 441349-84-4, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃Cl₂N₅O₃.
N-(Phthalimidoacetyl)glycine Ethyl Ester, CAS: 03/02/2641, stock: 8.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₅.
N-(tert-Butoxycarbonyl)-N-cyclopropylglycine, CAS: 182291-93-6, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.
L-Talose, CAS: 23567-25-1, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.
L-Valyl-L-histidine, CAS: 13589-07-6, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₄O₃.
Ganciclovir Ηydrate, CAS: 1359968-33-4, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₅O₅.
N-(tert-Butoxycarbonyl)glycylglycine, CAS: 31972-52-8, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₅.
N-(tert-Butyloxycarbonyl)-N-[(1S,2R)-2-hydroxy-1,2-diphenylethyl]-glycine Ethyl Ester, CAS: 112741-70-5, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₅.
L-Xylose, CAS: 609-06-3, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.
Lacto-N-neotetraose, CAS: 13007-32-4, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅NO₂₁.
Ganciclovir Mono-O-acetate, CAS: 88110-89-8, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₅O₅.
Ganciclovir Mono-O-acetate-d5, CAS: 1246818-76-7, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₅N₅O₅.
N-(Triphenylmethyl)Glycine Ethyl Ester, CAS: 18514-46-0, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃NO₂.
N-2-Naphthalenyl-glycine 2-[(3,5-Dibromo-2,4-dihydroxyphenyl)methylene]hydrazide, CAS: 328541-79-3, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅Br₂N₃O₃.
Lactosamine, CAS: 13000-25-4, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₁₀.
Lactose-3’-sulfate, CAS: 159358-51-7, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₄S.
Ganciclovir Mono-O-propionate, CAS: 194159-18-7, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₅O₅.
N-4-(1-Pyrene)butyroylglycine, CAS: 228414-55-9, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉NO₃.
N-4-Acetamidophenylsulfonylglycine, CAS: 23776-98-9, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₅S.
Levoglucosenone, CAS: 37112-31-5, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.
Levothyroxine Glucose Adduct, CAS: /, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁I₄NO₉.
Ganciclovir Mono-O-propionate-d5, CAS: /, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₅N₅O₅.
N-Acetyl Glyphosate, CAS: 129660-96-4, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀NO₆P.
LG 100754, CAS: 180713-37-5, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆O₃.
Linamarin, CAS: 554-35-8, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₆.
Ganciclovir Sodium Salt, CAS: 107910-75-8, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₅NaO₄.
Ganciclovir Triphosphate Triethylamine Salt, CAS: 86761-38-8, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₅O₁₃P₃•xC₆H₁₅N.
N-Acetyl Glyphosate-13C2,15N, CAS: 1346598-31-9, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀¹⁵NO₆P.
N-Acetyl Glyphosate-d3, CAS: 1346604-36-1, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃NO₆P.
Ganciclovir Triphosphate-d5 Triethylamine Salt, CAS: /, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₅N₅O₁₃P₃ •x(C₆H₁₅N).
N-Acetyl-4’-tetrahydropyranylglycine, CAS: 1219171-26-2, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₄.
N-Acetylglycinamide, CAS: 2620-63-5, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₂.
Luseogliflozin, CAS: 898537-18-3, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₆S.
N-Acetylglycine, CAS: 543-24-8, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₃.
N-Acetylglycine N-Methylamide-d8, CAS: 1219802-57-9, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₈N₂O₂.
Maltodecaose, CAS: 6082-21-9, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₁₀₂O₅₁.
Maltododecaose, CAS: 58634-79-0, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₂H₁₂₂O₆₁.
Iso Ganciclovir, CAS: 86357-09-7, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₄.
N-Acetylglycine-13C2,15N, CAS: 1202222-42-1, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₂H₇¹⁵NO₃.
N-Acetylglycine-d5, CAS: 1219805-82-9, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₅NO₃.
Maltoheptaose, CAS: 34620-78-5, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₃₆.
Maltoheptaose (>80%), CAS: 34620-78-5, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₇₂O₃₆.
N,O-Ditrityl Ganciclovir, CAS: 109082-85-1, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₄₁N₅O₄.
N-(L-Valyl) Valganciclovir Hydrochloride, CAS: /, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂ClN₇O₆.
N-Allyl Glycine Hydrochloride, CAS: 3182-78-3, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂ • HCl.
N-​(3-​Methylbenzoyl)​-glycine-d7 Ethyl Ester, CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈D₇NO₃.
Maltohexaose, CAS: 34620-77-4, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂O₃₁.
Maltononaose, CAS: 6471-60-9, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₉₂O₄₆.
N-Acetyl-di-O-acetyl Ganciclovir, CAS: 86357-14-4, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₅O₇.
N-​Boc-​L-​cyclohexylglycine, CAS: 109183-71-3, stock: 2.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.
N-​Ethyl-​N-​[(heptadecafluorooct​yl)​sulfonyl]​-​glycine 1,​1-​Dimethylethyl Ester, CAS: 193529-58-7, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆F₁₇NO₄S.
Maltooctaose, CAS: 6156-84-9, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₄₁.
Maltooctaose, CAS: 66567-45-1, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂O₄₁.
N-Carbobenzyloxy-L-valinyl-ganciclovir, CAS: 194154-40-0, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₆O₇.
N-Carbobenzyloxy-L-valinyl-ganciclovir-d5, CAS: /, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅N₆O₇.
N-​[(2E)​-​1-​Oxo-​2-​buten-​1-​yl]​-​glycine Methyl Ester, CAS: 1026721-13-0, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.
N-Benzyl Glycine Hydrochloride, CAS: 7689-50-1, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂ • HCl.
Maltopentose, CAS: 34620-76-3, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂₆.
Maltotetradecaose, CAS: 107882-52-0, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₄H₁₄₂O₇₁.
N-Methyl Valganciclovir Hydrochloride (Mixture of Diastereomers), CAS: /, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₆O₅ • x HCl.
N-Methyl Valganciclovir-d5 Hydrochloride, CAS: /, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀D₅ClN₆O₅.
N-Benzylglycine, CAS: 17136-36-6, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.
Maltotetraose, CAS: 34612-38-9, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
Maltotetraose Deuterated, CAS: /, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
N-Methyl-N-benzyloxycarbonyl O-Acetyl Valganciclovir, CAS: /, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₆O₈.
N-Methyl-N-benzyloxycarbonyl Valganciclovir, CAS: /, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₆O₇.
N-Benzylglycine Ethyl Ester Hydrochloride, CAS: 6344-42-9, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO₂.
N-Benzylidene-DL-phenylglycine Ethyl Ester, CAS: 77290-52-9, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.
Maltotriose Monohydrate, CAS: 207511-08-8, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₆ • x(H ₂O).
Maltoundecose, CAS: 50270-86-5, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₆H₁₁₂O₅₆.
N-[7-[[2-(Acetyloxy)-1-[(acetyloxy)methyl]ethoxy]methyl]-6,7-dihydro-6-oxo-1H-purin-2-yl]-acetamide, CAS: 86357-17-7, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₅O₇.
Gamithromycin, CAS: 145435-72-9, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₆N₂O₁₂.
N-Benzylideneglycine Ethyl Ester, CAS: 40682-54-0, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.
N-Benzyloxycarbonylglycine Thioamide, CAS: 49548-40-5, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂S.
Memantine-Glucose Adduct, CAS: /, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₅.
Metformin Hydrochloride, CAS: 1115-70-4, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂ClN₅.
O-Acetyl N-Benzyloxycarbonyl Valganciclovir, CAS: 194159-22-3, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₆O₈.
Gamithromycin-d4 (Major), CAS: /, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₁D₅N₂O₁₂.
N-Despropyl Gamithromycin, CAS: 145388-07-4, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₇₀N₂O₁₂.
N-beta-Aminoethyl-glycine Ethyl Ester Dihydrochloride, CAS: 24123-04-4, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆Cl₂N₂O₂.
Methoxy Oxo-dapagliflozin, CAS: /, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁ClO₇.
Methyl 1-​C-​[4-​Chloro-​3-​[(4-​ethoxyphenyl)​methyl]​phenyl]​-​L-​glucopyranoside, CAS: /, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClO₇.
O-Acetyl N-Benzyloxycarbonyl Valganciclovir-d5, CAS: 1356354-05-6, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₅N₆O₈.
O-Methylganciclovir, CAS: 108436-45-9, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₅O₄.
N-BOC-(2-Fluorophenyl)glycine, CAS: 161330-30-9, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆FNO₄.
Methyl 4-Deoxy-4-fluoro-α-D-glucose, CAS: 56926-53-5, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃FO₅.
Methyl 4-Deoxy-4-fluoro-α-D-glucose Tribenzoate, CAS: 84065-98-5, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅FO₈.
Trimethylacetic Anhydride, CAS: 1538-75-6, stock: 4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₃.
Valganciclovir Hydrochloride, CAS: 175865-59-5, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃ClN₆O₅.
N-Boc-(4’-chlorophenyl)glycine, CAS: 209525-73-5, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆NO₄Cl.
N-Boc-2,2,6,6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic Acid, CAS: 124843-12-5, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇N₂O₅.
Methyl 4-Deoxy-α-D-glucopyranoside, CAS: 13241-00-4, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₅.
Valganciclovir N3,N3’-Methylene Dimer, CAS: 1401661-96-8, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄N₁₂O₁₀.
Valganciclovir-d5 Hydrochloride, CAS: /, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₅ClN₆O₅.
N-Boc-2-(1-trifluoromethylcyclopropyl)-DL-glycine, CAS: 1098188-08-9, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆NO₄F₃.
N-Boc-2-(3’-chlorophenyl)-L-glycine, CAS: 1217643-80-5, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆NO₄Cl.
Methyl 6-Bromo-6-deoxy-α-D-talopyranose, CAS: /, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃BrO₅.
Metrizamide, CAS: 31112-62-6, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂I₃N₃O₈.
Valganciclovir-d8, CAS: 1132088-63-1, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₈N₆O₅.
N-Boc-2-(methylthio)ethylamine, CAS: 174360-08-8, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂S.
N-Boc-2-(methylthio)ethylamine-d3, CAS: /, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄D₃NO₂S.
Mouse G6PC(Glucose-6-Phosphatase, Catalytic) ELISA Kit (96T), CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse G6PD(Glucose 6 Phosphate Dehydrogenase) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-2-(piperidin-3-yl)glycine, CAS: 1219421-12-1, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₂O₄.
Mouse Gale (UDP-glucose 4-epimerase) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Gfod1 (Glucose-fructose oxidoreductase domain-containing protein 1) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-2-cyclopropyl-L-glycine, CAS: 155976-13-9, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.
N-Boc-4-Hydroxyphenyl-DL-glycine, CAS: 53249-34-6, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₅.
Mouse Gfod2 (Glucose-fructose oxidoreductase domain-containing protein 2) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-D-cyclohexylglycine, CAS: 70491-05-3, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.
N-Boc-D-cyclohexylglycine-d11, CAS: /, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₁₁NO₄.
Mouse GLUT1(Glucose Transporter 1) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse GLUT4(Glucose Transporter 4) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-DL-cyclohexylglycine, CAS: 35264-05-2, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.
N-Boc-DL-cyclohexylglycine-d11, CAS: /, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₁₁NO₄.
Mouse GPI(Glucose 6 Phosphate Isomerase) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse HSPA5(78 kDa glucose-regulated protein) ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-glycine, CAS: 4530-20-5, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄.
N-Boc-glycine Ethyl Ester, CAS: 14719-37-0, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.
Mouse Slc2a2 (Solute carrier family 2, facilitated glucose transporter member 2) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-glycine N-Carboxyanhydride, CAS: 142955-50-8, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₅.
Mouse Slc2a8 (Solute carrier family 2, facilitated glucose transporter member 8) ELISA Kit (96T), CAS: /, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Mouse Tgds (dTDP-D-glucose 4,6-dehydratase) ELISA Kit (96T), CAS: /, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Boc-glycine-13C, CAS: 145143-02-8, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³CH₁₃NO₄.
N-Boc-L-Allylglycine, CAS: 90600-20-7, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.
Mouse Ugdh (UDP-glucose 6-dehydrogenase) ELISA Kit (96T), CAS: /, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Muramic Acid, CAS: 1114-41-6, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₇.
N-Boc-L-cyclohexylglycine-d11, CAS: /, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₁₁NO₄.
Muramic Acid-15N, CAS: /, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇¹⁵NO₇.
N,N’-Diacetylchitobiose, CAS: 35061-50-8, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₂O₁₁.
N-Boc-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-glycine, CAS: /, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₈H₁₂₁N₁₁O₁₆.
N-Boc-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-glycine Methyl Ester, CAS: /, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₉H₁₂₃N₁₁O₁₆.
N-((3S,4S,5R,6R)-5-Amino-4-hydroxy-6-methyltetrahydro-2H-pyran-3-yl)acetamide, CAS: /, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₃.
N-(2-Deoxy-D-glucos-2-yl)-L-asparagine, CAS: 16745-12-3, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₈.
N-Boc-N-cyclohexylglycine, CAS: 166739-13-5, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₄.
N-Boc-N-ethyl-glycine, CAS: 149794-10-5, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.
N-(2-Deoxy-α,β-D-glucopyranosyl)-S-nitroso-N-acetyl-D,L-penicillamine, CAS: 188849-82-3, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃N₃O₈S.
N-(4-Azidosalicyl)-6-amido-6-deoxy-glucopyranose, CAS: 86979-66-0, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₇.
N-Boc-S-Bzl-L-Cys-Gly-OBzl, CAS: 83283-22-1, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₂O₅S.
N-Boc-S-Bzl-L-Cys-Gly-OBzl-13C2,15N, CAS: 874462-69-8, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₂H₃₀N¹⁵NO₅S.
N-(Acetyl-d3)-D-glucosamine 6-Sulfate Sodium Salt, CAS: /, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃NNaO₉S.
N-(Benzyloxycarbonyl)ethanolamine, CAS: 77987-49-6, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.
N-Carbobenzoxyglycine, CAS: 1138-80-3, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.
N-(β-D-Glucopyranosyl)-N’-[(2-methanethiosulfonyl)ethyl] Urea, CAS: 550325-52-5, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₈S₂.
N-(n-Octyl) Glucosamine, CAS: 93125-46-3, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₉NO₅.
N-Carbobenzoxyglycine-13C2,15N, CAS: 525587-92-2, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₁¹⁵NO₄.
N-Carbonylglycine Methyl Ester, CAS: 30988-17-1, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO₃.
N-Acetyl-D-glucosamine, CAS: 7512-17-6, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₆.
N-Acetyl-D-Glucosamine 6-Acetate, CAS: 131832-93-4, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₇.
N-Cbz-glycine hydrazide, CAS: 5680-83-1, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₃.
N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly-OBzl, CAS: 97924-38-4, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₁N₃O₈S.
N-Acetyl-D-glucosamine 6-Sulfate Sodium Salt, CAS: 108321-79-5, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄NNaO₉S.
N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzl, CAS: 874462-72-3, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇¹³C₂H₄₁N₂¹⁵NO₈S.
N-Chloroacetylglycine, CAS: 6319-96-6, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NO₃Cl.
N-Acetyl-D-glucosamine-13C, CAS: 253679-94-6, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.
N-Acetyl-D-glucosamine-13C6, CAS: /, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₁₅NO₆.
N-Acetyl-D-glucosamine-13C615N, CAS: 478529-41-8, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₁₅¹⁵NO⁶.
N-Acetyl-D-glucosamine-d3, CAS: 77369-11-0, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₃NO₆.
N-Crotonylglycine, CAS: 1026721-15-2, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₃.
N-Acetyl-D-[1-13C15N]glucosamine, CAS: 478529-40-7, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅¹⁵NO₆.
N-Acetyl-D-[15N]glucosamine, CAS: 478518-85-3, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅¹⁵NO₆.
N-Crotonylglycine-13C2,15N, CAS: /, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₉¹⁵NO₃.
N-D-Glucopyranosyl-glycine Sodium Salt, CAS: 117072-57-8, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄NNaO₇.
N-Acetyl-D-[2-13C]glucosamine, CAS: 478529-39-4, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₇H₁₅NO₆.
N-Acetyllactosamine, CAS: 32181-59-2, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₁₁.
N-Des(2-diethylamino) Metoclopramide Acetic Acid, CAS: 65567-29-5, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂O₄.
N-Acetyllactosamine 6,6’-Disulfate-d3 Disodium Salt, 90%, CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀D₃NNa₂O₁₇S₂.
N-Acetyllactosamine 6-Sulfate Sodium Salt, 90%, CAS: 145447-78-5, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄NNaO₁₄S.
N-Dodecanoylglycine, CAS: 7596-88-5, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇NO₃.
N-Dodecanoylglycine-d2, CAS: /, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅D₂NO₃.
N-Acetyllactosamine 6-Sulfate-d3 Sodium Salt, CAS: /, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁D₃NNaO₁₄S.
N-Acetylquinovosamine, CAS: 40614-71-9, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₅.
N-Dodecanoylglycine-d23, CAS: /, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₄D₂₃NO₃.
N-Ethyl-N-(perfluoro-1-octanesulfonyl) Glycine, CAS: 2991-50-6, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈F₁₇NO₄S.
N-Allyloxycarbonyl-β-lactosamine, CAS: 209977-55-9, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NO₁₂.
N-Boc-D-glucosamine, CAS: 75251-80-8, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₇.
N-Ethyl-N-(perfluoro-1-octanesulfonyl) Glycine-d5, CAS: 1265205-97-7, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃D₅F₁₇NO₄S.
N-Ethylglycine, CAS: 627-01-0, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.
N-Carbobenzoxy-1,4-diaminobutane Hydrochloride, CAS: 18807-73-3, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂ • HCl.
N-Cbz-L-leucine, CAS: 2018-66-8, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.
N-Fmoc-2-(N-boc-piperidin-3-yl)glycine, CAS: 494210-72-9, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.
N-Didesmethyl N-Methylaminomethyl Metformin, CAS: /, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂N₆.
N-Ethyl-D-glucamine, CAS: 14216-22-9, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉NO₅.
N-Formylglycine, CAS: 2491-15-8, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅NO₃.
N-Formylglycine Ethyl Ester, CAS: 3154-51-6, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₉NO₃.
N-Formylglycine-13C2 Ethyl Ester, CAS: 1391051-73-2, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₉NO₃.
N-tert-Butoxycarbonyl Anabasine D-Glucose-2,3,4,6-tetraacetate Bromide, CAS: /, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁BrN₂O₁₁.
N-Glycylglycine, CAS: 556-50-3, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₃.
N-Glycylglycine-13C4, CAS: /, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₇NO₄.
N-[1,2-13C2]Acetyl-D-glucosamine, CAS: 157668-96-7, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₅NO₆.
N-Hydroxy Melagatran, CAS: 192939-72-3, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁N₅O₅.
N-[1,2-13C2]Acetyl-D-[1-13C,15N]glucosamine, CAS: 478529-43-0, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₃H₁₅¹⁵NO₆.
N-[1,2-13C2]Acetyl-D-[UL-13C6,15N]glucosamine, CAS: 478529-44-1, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₈H₁₅¹⁵NO₆.
N-Hydroxy Melagatran-d11, CAS: /, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₁₁N₅O₅.
N-[1,2-13C2]Acetyl-D-[UL-13C6]glucosamine, CAS: 478529-42-9, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₈H₁₅NO₆.
N-[1-13C]Acetyl-D-glucosamine, CAS: 478518-87-5, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.
N-Iso Valerylglycine-13C2,15N, CAS: /, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₁₃¹⁵NO₃.
N-[2-13C]Acetyl-D-glucosamine, CAS: 478518-89-7, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₁₅NO₆.
N6-​[Bis(4-​methoxyphenyl)​methyl]​-​N2-​[(phenylmethoxy)​carbonyl]​-​L-​lysine Phenylmethyl Ester, CAS: 1820794-34-0, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₀N₂O₆.
N-Isobutyrylglycine-13C2,15N, CAS: /, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₁¹⁵NO₃.
N-Isopropyl-N-methylglycine, CAS: 108957-96-6, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.
N6-​[Bis(4-​methoxyphenyl)​methyl]​-​N6-​[3,​6-​dideoxy-​1,​2-​O-​(1-​methylethylidene)​-​α-​D-​ribo-​hexofuranos-​6-​yl]​-​N2-​[(phenylmethoxy)​carbonyl]​-L-​lysine Phenylmethyl Ester, CAS: 1820794-59-9, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₄N₂O₁₀.
NGA2 Glycan, CAS: 84808-02-6, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₈₄N₄O₃₆.
N-Lauroylsarcosine, CAS: 97-78-9, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₉NO₃.
N-Methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoyl-(2S)-2-aminobutanoyl-N-methyl-glycine Methyl Ester, CAS: 286852-20-8, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₁₁₇N₁₁O₁₄.
Nigerose, CAS: 497-48-3, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁.
Nα-Z-L-Lysine Benzyl Ester Benzenesulfonate Salt, CAS: 68973-36-4, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₄.C₆H₆O₃S.
N-Methyl-N-(2-pyridinylmethyl)glycine Dihydrochloride Hydrate, CAS: 1315173-05-7, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₂ • 2[HCl] • H ₂O.
Nojirimycin-1-Sulfonic Acid, CAS: 114417-84-4, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₇S.
N-Methyl-N-(3-pyridinylmethyl)glycine Dihydrochloride, CAS: 1185294-06-7, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₂ • 2[HCl].
N-Methyl-N-(4-methylbenzyl)glycine, CAS: 1041538-08-2, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂ • HCl.
Nonasaccharide Glc4Xyl3Gal2, CAS: 129865-06-1, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₈₆O₄₃.
N-Methyl-N-(methylsulfonyl)glycine, CAS: 115665-52-6, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₄S.
N-Methylperfluoro-1-octanesulfonamidoacetic Acid, CAS: 2355-31-9, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆F₁₇NO₄S.
N-Methylperfluoro-1-octanesulfonamidoacetic Acid-d3, CAS: 1400690-70-1, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₃D₃F₁₇NO₄S.
O-(5-Acetamido-4,7,8,9-tetra-O-acetyl-3-thiophenyl-α-neuraminosyl Methyl Ester)-2-α-3-O-(6-O-benzyl-β-D-galactopyranosyl)-1-β-4-O-[6-deoxy-2,3,4-tri-O-benzyl-α-L-galactopyranosyl-(1-α-3)]-2-(acetylamino)-2-deoxy-1,6-di-O-benzyl-α-D-glucose, CAS: /, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₈H₁₀₂N₂O₂₇S.
O-2-(Acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-O-(N-acetyl-β-muramosyl)-(1→4)-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→4)-N-acetylmuramic Acid, CAS: 13538-21-1, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₂N₄O₂₅.
N-Nitroso Sarcosine Methyl Ester, CAS: 51938-19-3, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₃.
O-​β-​D-​glucopyranosyl-​(1→4)​-​O-​β-​D-​glucopyranosyl-​(1→3)​-​O-​β-​D-​glucopyranosyl-​(1→4)​-D-​Glucose, CAS: 103762-93-2, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
O-​β-​D-​glucopyranosyl-​(1→4)​-​O-​β-​D-​glucopyranosyl-​(1→4)​-​O-​β-​D-​glucopyranosyl-​(1→3)​-D-​Glucose, CAS: 58484-02-9, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₂₁.
N-Nitroso(2-hydroxyethyl)glycine, CAS: 80556-89-4, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₄.
N-Nitroso-N-(phosphonomethyl)glycine, CAS: 56516-72-4, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇N₂O₆P.
O-Desethyl Dapagliflozin, CAS: 864070-37-1, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClO₆.
O-Isobutyl ((3aR,7S,9S,9aR)-2,2,7-Trimethylhexahydro-[1,3]dioxolo[4’,5’:5,6]pyran[3,2-d][1,3]dioxin-9-yl) Sulfate, CAS: /, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O₉S.
N-Nitrososarcosine, CAS: 13256-22-9, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆N₂O₃.
N-Nitrososarcosine-d3, CAS: 1189871-94-0, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃D₃N₂O₃.
O-Isobutyl ((3aR,7S,9S,9aR)-2,2,7-Trimethylhexahydro-[1,3]dioxolo[4’,5’:5,6]pyran[3,2-d][1,3]dioxin-9-yl) Sulfite, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O₈S.
N-Octanoyl-d15-glycine, CAS: /, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₁₅NO₃.
N-Octanoylglycine, CAS: 14246-53-8, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₃.
O-Pentaacetyl O-Desethyl Dapagliflozin, CAS: /, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁ClO₁₁.
O-Trimethyl GFT-505, CAS: 923978-25-0, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₄S.
N-Octanoylglycine-13C2,15N, CAS: /, stock: 1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₉¹⁵NO₃.
N-Phenylacetylglycine, CAS: 500-98-1, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.
Okadaic Acid, CAS: 78111-17-8, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₈O₁₃.
N-Phenylglycine, CAS: 103-01-5, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.
N-Phenylglycine Ethyl Ester, CAS: 2216-92-4, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.
Oleanolic Acid 3-O-Glucuronide, CAS: 26020-14-4, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₆O₉.
Oleanolic Acid-d3 3-O-Glucuronide, CAS: /, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₃D₃O₉.
N-Phenylglycine Isopentyl Ester, CAS: 100618-40-4, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.
N-Phenylglycine Potassium Salt, CAS: 19525-59-8, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈KNO₂.
Oseltamivir Glucose Adduct 1, CAS: /, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₈N₂O₉.
Oseltamivir-glucose Adduct 2, CAS: /, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₂O₈.
Galaxolide (Mixture of Diastereomers), CAS: 1222-05-5, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O.
N-Phenylglycine-13C2,15N, CAS: /, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₉¹⁵NO₂.
N-Phenylglycinonitrile, CAS: 3009-97-0, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂.
Galaxolide (solution 50% in diethyl phthalate), CAS: 1222-05-5, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O.
N-Phenylsulfonyl-Sarcosine, CAS: 46376-16-3, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄S.
N-Phthaloylglycine, CAS: 4702-13-0, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₄.
Paucimannose, CAS: 70858-45-6, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₈N₂O₂₆.
PFK 15, CAS: 4382-63-2, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂N₂O.
Galaxolide-13C3 (Mixture of Diastereomers), CAS: /, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³C₃H₂₆O.
Galaxolide-d12 (Mixture of Diastereomers), CAS: /, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₁₂O.
N-Phthaloylglycine 2-[5-Amino-3-carboxy-2,4,6-triiodobenzoyl]aminoethyl Ester, CAS: 1798026-94-4, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄I₃N₃O₇.
N-Phthaloylglycylglycine, CAS: 3916-40-3, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₅.
Phloretin, CAS: 60-82-2, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₅.
Phloridzin, CAS: 60-81-1, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄O₁₀.
Galaxolide-d5 (Mixture of Diastereomers), CAS: /, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₅O.
rac Galaxolidone (Mixture of Diastereomers), CAS: 507442-49-1, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₂.
N-Stearoyl-glycine, CAS: 6333-54-6, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₉NO₃.
Potassium Ferricyanide(III)-15N6, CAS: /, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆FeK₃¹⁵N₆.
rac Galaxolidone Lactol, CAS: 946845-14-3, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆O₂.
N-tert-Butoxycarbonyl-N-[3-(tert-butoxycarbonylamino)propyl]glycine, CAS: 192124-66-6, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈N₂O₆.
Pramipexole Glucose Adduct (Mixture of diastereomers), CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇N₃O₅S.
Pregn-5-ene-3,20-dione Bis(cyclic ethylene acetal), CAS: 7093-55-2, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₄.
rac Galaxolidone-d5 (Mixture of Diastereomers), CAS: /, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₅O₂.
N-tert-Butyloxycarbonyl Glutathione Dimethyl Diester, CAS: 120033-58-1, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉N₃O₈S.
Primeverose, CAS: 26531-85-1, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₁₀.
Proligestone, CAS: 23873-85-0, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₄.
N-tert-Butyloxycarbonyl Glutathione Dimethyl Diester Disulfide Dimer, CAS: 566172-19-8, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₆N₆O₁₆S₂.
N-Tosylglycine, CAS: 1080-44-0, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄S.
N-Trifluoroacetylglycine, CAS: 383-70-0, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄F₃NO₃.
Quercetin-3-O-β-D-glucose-7-O-β-D-gentiobioside, CAS: 60778-02-1, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₀O₂₂.
N-Trifluoroacetylglycine N-Succinimidyl Ester, CAS: 3397-30-6, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇F₃N₂O₅.
rac Secoisolariciresinol Diglucoside, CAS: 158932-33-3, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆O₁₆.
rac Secoisolariciresinol Diglucoside-d4, CAS: /, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂D₄O₁₆.
N-Tritylglycine Hydrazide, CAS: 116435-38-2, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₃O.
Rat G-6-Pase/G6PT/GSD(Glucose 6 Phosphate) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat G6PD(Glucose 6 Phosphate Dehydrogenase) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-Valerylglycine-13C2,15N, CAS: /, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₁₃¹⁵NO₃.
N-[(1,1-Dimethylethoxy)carbonyl]-n-methyl-glycine [2-(Methylamino)-3-pyridinyl]methyl Ester, CAS: 1180002-01-0, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O₄.
Rat Gale (UDP-glucose 4-epimerase) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat GLUT3(Glucose Transporter 3) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-[(1,1-Dimethylethoxy)carbonyl]glycine Methyl Ester, CAS: 31954-27-5, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.
N-[(1,1-Dimethylethoxy)carbonyl]glycine-2,2-d2, CAS: 42492-65-9, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁D₂NO₄.
Rat GLUT4(Glucose Transporter 4) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Gpi(Glucose-6-phosphate isomerase) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-N-(2,3-dihydro-1H-inden-2-yl)glycine, CAS: 83398-08-7, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₅.
N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl-N-(2,3-dihydro-1H-inden-2-yl)glycine-d3, CAS: /, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₃N₂O₅.
Rat Hspa5(78 kDa glucose-regulated protein) ELISA Kit (96T), CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat SGLT2(Sodium/glucose cotransporter 2) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-[(1S,2R)-2-Hydroxy-1,2-diphenylethyl]-glycine Ethyl Ester, CAS: 100678-82-8, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₃.
N-[(2-Chloro-6-nitrophenyl)methyl]glycine Ethyl Ester, CAS: 50608-25-8, stock: 4.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₂O₄.
Rat Slc2a1(Solute carrier family 2, facilitated glucose transporter member 1) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Slc2a2 (Solute carrier family 2, facilitated glucose transporter member 2) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-[(2R)-2-(3-Chlorophenyl)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-N-[(1,1-dimethylethoxy)carbonyl]-glycine Methyl Ester, CAS: 174891-01-1, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆ClNO₅Si.
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine, CAS: 1094089-46-9, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄.
Rat Slc2a2(Solute carrier family 2, facilitated glucose transporter member 2) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Slc2a8 (Solute carrier family 2, facilitated glucose transporter member 8) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
N-[(2R)-2-Hydroxy-2-(3-hydroxyphenyl)ethyl]-N-methyl-glycine Sodium Salt, CAS: /, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NNaO₄.
Rat Slc5a1(Sodium/glucose cotransporter 1) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Ugdh (UDP-glucose 6-dehydrogenase) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rebaudioside A, CAS: 58543-16-1, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₀O₂₃.
Rebaudioside A (13CD2), CAS: /, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇¹³CH₅₈D₂O₁₈.
Rebaudioside B, CAS: 58543-17-2, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₀O₁₈.
Rebaudioside B (13CD2), CAS: /, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇¹³CH₅₈D₂O₁₈.
N-[(3β,7α)-7-Hydroxy-24-oxo-3-(sulfooxy)chol-5-en-24-yl]glycine Disodium Salt, CAS: 1638974-20-5, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀D₅NNa₂O₈S.
N-[(3β,7α)-7-Hydroxy-24-oxo-3-(sulfooxy)chol-5-en-24-yl]glycine-13C2,15N Disodium Salt, CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³C₂H₃₉¹⁵NNa₂O₈S.
Rebaudioside C, CAS: 63550-99-2, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₀O₂₂.
Rebaudioside C (13CD2), CAS: /, stock: 10g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃¹³CH₆₈D₂O₂₂.
N-[(3β,7α)-7-Hydroxy-24-oxo-3-(sulfooxy)chol-5-en-24-yl]glycine-d5 Disodium Salt, CAS: /, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀D₅NNa₂O₈S.
Rebaudioside D, CAS: 63279-13-0, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₈₀O₂₅.
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine, CAS: 808118-40-3, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₅.
Rebaudioside D (13CD2), CAS: /, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉¹³CH₇₈D₂O₂₈.
Robison Ester Monosodium Salt, CAS: 54010-71-8, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₉P • Na.
N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine-d3, CAS: 1794767-93-3, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃D₃N₂O₅.
N-[(4-Methoxyphenyl)sulfonyl]-N-phenylglycine, CAS: 117309-27-0, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₅S.
Ruthenium(III) Chloride, CAS: 10049-08-8, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₃Ru.
Rutinose Heptaacetate, CAS: 29202-64-0, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆O₁₇.
N-[(5-Chloro-2-thienyl)carbonyl]glycine, CAS: 873009-45-1, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃S.
N-[(6-Chloro-3-pyridinyl)carbonyl]-glycine, CAS: 1099143-66-4, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClN₂O₃.
Saxagliptin Glucose Adduct, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅N₃O₇.
N-[(7α)-7-Hydroxy-3,24-dioxochol-4-en-24-yl]glycine, CAS: 117590-83-7, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉NO₅.
N-[(7α)-7-Hydroxy-3,24-dioxochol-4-en-24-yl]glycine-13C2,15N, CAS: /, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³C₂H₃₉¹⁵NO₅.
Schisandrin C, CAS: 61301-33-5, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄O₆.
Sodium (3aR,7S,9S,9aR)-2,2,7-Trimethylhexahydro-[1,3]dioxolo[4’,5’:5,6]pyrano[3,2-d][1,3]dioxin-9-yl Sulfate, CAS: /, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NaO₉S.
Sodium Starch Glycolate, CAS: 9063-38-1, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.
N-[(Benzyloxy)carbonyl]glycylglycine, CAS: 2566-19-0, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₅.
N-[(Dimethylamino)carbonyl]glycine, CAS: 1060817-29-9, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₃.
N-[1-Deoxy-2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranos-1-yl]glycine, CAS: 171081-86-0, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₇.
SRT1720 Hydrochloride, CAS: 1001645-58-4, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃N₇OS•xHCl.
Statil, CAS: 72702-95-5, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂BrFN₂O₃.
Anhydro Galanthamine, CAS: 664995-65-7, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.
N-[1-Oxo-2-(phenylmethyl)-2-propenyl]glycine, CAS: 76932-18-8, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.
N-[1-Oxo-2-(phenylmethyl)-2-propenyl]glycine Ethyl Ester, CAS: 660848-81-7, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₃.
Stevioside (90%), CAS: 57817-89-7, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₀O₁₈.
Stevioside-13C,d2 (90%), CAS: /, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇¹³CH₅₈D₂O₁₈.
N-[2-(4-Ethoxyphenyl)acetyl]glycine, CAS: 1098362-68-5, stock: 3.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.
N-[2-(Fmoc-amino)-ethyl]glycine tert-butyl ester hydrochloride, CAS: 169396-88-7, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClN₂O₄.
Streptozotocin, CAS: 18883-66-4, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅N₃O₇.
N-[2-(Mercaptomethyl)-1-oxo-3-phenylpropyl]glycine Methyl Ester, CAS: 83960-22-9, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃S.
N-[2-[(Acetylthio)methyl]-1-oxo-3-phenylpropyl]glycine Methyl Ester, CAS: 81110-05-6, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄S.
Syringaresinol Diglucoside, CAS: 96038-87-8, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₆O₁₈.
Syringaresinol Diglucoside-d6, CAS: /, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀D₆O₁₈.
Syringin, CAS: 118-34-3, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₉.
N-[4-Chloro-2-(2-chlorobenzoyl)phenyl]-N-[(3,4-dimethoxyphenyl)sulfonyl]glycine, CAS: 167400-96-6, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉Cl₂NO₇S.
Thiocellobiose, CAS: 80951-92-4, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₀S.
N-[4-Chloro-2-(2-chlorobenzoyl)phenyl]-N-[(3,4-dimethoxyphenyl)sulfonyl]glycine Phenylmethyl Ester, CAS: 140916-69-4, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₅Cl₂NO₇S.
Thymol O-β-D-Glucuronide, CAS: 7702-71-8, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₇.
Thymol O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₇.
N-[8-[[(4-Aminocyclohexyl)amino]carbonyl]-2-(2-methylphenyl)imidazo[1,2-a]pyridin-3-yl]glycine Methyl Ester, CAS: 439835-99-1, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₅O₃.
N-[8-[[[[3-(Aminomethyl)phenyl]methyl]amino]carbonyl]-2-(2-methylphenyl)imidazo[1,2-a]pyridin-3-yl]glycine Methyl Ester, CAS: 439832-79-8, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₃.
Thymol Sulfate Potassium Salt, CAS: 172265-90-6, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃KO₄S.
TIQ-A, CAS: 420849-22-5, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇NOS.
N-[8-[[[[3-(aminomethyl)phenyl]methyl]amino]carbonyl]-2-(3-methylphenyl)imidazo[1,2-a]pyridin-3-yl]glycine Methyl Ester, CAS: 439833-74-6, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₃.
N-[8-[[[[3-(Aminomethyl)phenyl]methyl]amino]carbonyl]-2-phenylimidazo[1,2-a]pyridin-3-yl]glycine Ethyl Ester, CAS: 439833-11-1, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₃.
Tolimidone, CAS: 41964-07-2, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₂.
N-[bis(Methylthio)methylene]glycine Methyl Ester, CAS: 58091-08-0, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂S₂.
Trelagliptin, CAS: 865759-25-7, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₅O₂.
Trelagliptin Trifluoroacetic Acid Salt, CAS: 928201-45-0, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁F₄N₅O₄.
N-[S-(2-Pyridylthio)cysteaminyl]ethylenediamine-N,N,N’,N’-tetraacetic Acid, Monoamide, Technical grade 90%, CAS: 143541-95-1, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₄O₇S₂.
N-[[2-(Methylthio)-5-thiazolyl]carbonyl]-glycine, CAS: 915125-11-0, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃S₂.
N-[[2-Furanylmethyl)amino]carbonyl]-glycine, CAS: 953885-34-2, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₄.
Triheptanoin, CAS: 620-67-7, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₄O₆.
Triheptanoin-d5, CAS: /, stock: 2.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉D₅O₆.
N-[[4-[2-(5-Methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine Methyl Ester, CAS: 331746-65-7, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₄.
Troglitazone, CAS: 97322-87-7, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₅S.
N-[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]-L-γ-glutamyl-L-cysteinylglycine Bimol. (2→2’)-Disulfide, CAS: 136346-25-3, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₄N₈O₁₆S₄.
Uridine 5’-Diphospho-α-D-glucose-13C6 Diammonium Salt, CAS: 904293-00-1, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀N₄O₁₇P₂.
Uridine 5’-Diphosphoglucose Disodium Salt, CAS: 28053-08-9, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂Na₂O₁₇P₂.
Vortioxetine Glucose Adduct, CAS: /, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₂O₅S.
Y-26763, CAS: 127408-31-5, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₄.
N2,N6-Bis[(phenylmethoxy)carbonyl]-L-lysyl]glycine 1,1-Dimethylethyl Ester, CAS: /, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇N₃O₇.
N2-Carboxy-N-(carboxymethyl)asparagine Tribenzyl Ester, CAS: 68802-36-8, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₂O₇.
Neuromedin B, Porcine, CAS: 87096-84-2, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₇₃N₁₅O₁₂S.
ZLN005, CAS: 49671-76-3, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂.
[1-13Cgal]Lactose Monohydrate, CAS: /, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₄O₁₂.
Nicotinuric Acid, CAS: 583-08-4, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₃.
Nicotinuric Acid-d4, CAS: 1216737-36-8, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₄N₂O₃.
[1-13Cglc]Lactose Monohydrate, CAS: 287100-62-3, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₄O₁₂.
[5-(4-Fluorophenyl)-2-thienyl][2-methyl-5-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)phenyl]-methanol, CAS: /, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃FO₁₀S.
Nitrilotriacetic Acid, CAS: 139-13-9, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₆.
Nitrilotriacetic Acid Disodium Salt, CAS: 15467-20-6, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NNa₂O₆.
[5-(4-Fluorophenyl)-2-thienyl][2-methyl-5-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)phenyl]-methanone, CAS: 1312811-00-9, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁FO₁₀S.
[6-13Cgal]Lactose Monohydrate, CAS: /, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³CH₂₄O₁₂.
Nitrilotriacetic Acid Trisodium Salt, CAS: 5064-31-3, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆NNa₃O₆.
Nα,Nε-Dibenzyloxycarbonyl-L-lysylglycine, CAS: 37941-54-1, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₃O₇.
[UL-13C12]Lactose Monohydrate, CAS: /, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₁₂H₂₄O₁₂.
[UL-13C6gal]Lactose, CAS: /, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₂₂O₁₁.
Nor Lidocaine Hydrochloride, CAS: 7729-94-4, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉ClN₂O.
Nor Lidocaine-d5 Hydrochloride, CAS: 1329497-00-8, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄D₅ClN₂O.
[UL-13C6glc]Lactose Monohydrate, CAS: /, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₂₄O₁₂.
[[3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinyl]methyl]carbamic Acid 1,1-Dimethylethyl Ester, CAS: 210034-86-9, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₄.
Nor Lidocaine-d6 Hydrochloride, CAS: /, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₆ClN₂O.
NPEC-caged-(S)-3,4-DCPG, CAS: 1257323-85-5, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₁₀.
NSC 379317, CAS: 23911-26-4, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₈.
Omidenepag, CAS: 1187451-41-7, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂N₆O₄S.
ON-01910 Sodium Salt, CAS: 1225497-78-8, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄NNaO₈S.
Org 24598, CAS: 372198-97-5, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀F₃NO₃.
Org 24598 Lithium Salt, CAS: 722456-08-8, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉F₃LiNO₃.
Oxalylglycine, CAS: 5262-39-5, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO₅.
Oxamic Acid, CAS: 471-47-6, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃NO₃.
p-Hydroxyphenylacetylglycine, CAS: 28116-23-6, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.
p-Hydroxyphenylacetylglycine-13C2,15N, CAS: /, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₁¹⁵NO₄.
p-NH₂-Bn-CHX-A”-DTPA, CAS: 1105741-38-5, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆N₄O₁₀.
p-SCN-Bn-CHX-A”-DTPA, CAS: 157380-45-5, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₄O₁₀S.
p-SCN-Bn-DTPA, CAS: 102650-30-6, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₄O₁₀S.
PACMA 31, CAS: 1401089-31-3, stock: 6.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₆S.
Papain (Technical Grade), CAS: 9001-73-4, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.
Perindoprilat Propylglycine Acyl-β-D-glucuronide, CAS: /, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆N₂O₁₁.
PF 04929113, CAS: 908115-27-5, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀F₃N₅O₄.
Phenyleneethylenetriamine Pentaacetic Acid, CAS: 126736-75-2, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₁₀.
Phenylglycine Ethyl Ester Hydrochloride, CAS: 879-48-1, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.
Phenylglycine Methyl Ester Hydrochloride, CAS: 15028-40-7, stock: 7.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₂.
Phenylmethyl N-[(1,1-Dimethylethoxy)carbonyl]-N-[2-oxo-2-(phenylmethoxy)ethyl]-glycine Ester, CAS: 179559-40-1, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₆.
Phthaloyl-glycine 4-nitorophenyl Ester, CAS: 21313-49-5, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀N₂O₆.
Piperazinedione-carbonyl D-Phenylglycyl-glycine, CAS: 2170771-47-6, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄O₆.
Pivaloylglycine-13C2,15N, CAS: /, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₁₃¹⁵NO₃.
PNU 142300, CAS: 368891-69-4, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀FN₃O₆.
PNU 142586 Sodium Salt, CAS: /, stock: 4.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉FN₃NaO₆.
Prednisolamate, CAS: 5626-34-6, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉NO₆.
Prednisolamate-D10, CAS: /, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉D₁₀NO₆.
Propionyl Glycine, CAS: 21709-90-0, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₃.
Propionyl-d5 Glycine, CAS: /, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₅NO₃.
Propyl Methanethiosulfonate, CAS: 24387-69-7, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀O₂S₂.
Quin 2 Potassium Salt Hydrate, CAS: 149022-19-5, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₃O₁₀ • x(H ₂O) • x(K).
Quin 2-AM, CAS: 83104-85-2, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₃N₃O₁₈.
Quin II, CAS: 83014-44-2, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₃O₁₀.
rac-Terpenylic Acid, CAS: 116-51-8, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄.
Racecadotril, CAS: 81110-73-8, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄S.
Racecadotril-d5, CAS: 1246815-11-1, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₅NO₄S.
Rat Dmgdh (Dimethylglycine dehydrogenase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Gatm (Glycine amidinotransferase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Gcsh (Glycine cleavage system H protein, mitochondrial) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Glyat (Glycine N-acyltransferase) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Gnmt (Glycine N-methyltransferase) ELISA Kit (96T), CAS: /, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Rat Pam (Peptidyl-glycine alpha-amidating monooxygenase) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.
Retorphan, CAS: 112573-72-5, stock: 7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄S.
Retorphan-d5, CAS: /, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₅NO₄S.
S(+)-N-(2-(2-Thienyl)ethyl)-2-chlorophenyl Glycine Methyl Ester Hydrochloride, CAS: 141109-19-5, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇Cl₂NO₂S.
S,S’-Ethylenebis(glutathione), CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆N₆O₁₂S₂.
S,S’-Ethylenebis(glutathione)-d4, CAS: /, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂D₄N₆O₁₂S₂.
S,S’-Ethylenebis(glutathione)-d4 Dihydrochloride, CAS: /, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄D₄Cl₂N₆O₁₂S₂.
S-(1-Methyl-2-hydroxyethyl)glutathione(Mixture of Diastereomers), CAS: 1356019-76-5, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃N₃O₇S.
S-(1-Methyl-2-hydroxyethyl)glutathione-d6, CAS: /, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇D₆N₃O₇S.
S-(2-Hydroxyethyl)-N-tert-butyloxycarbonyl Glutathione, CAS: /, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉N₃O₉S.
S-(2-Hydroxyethyl)-N-tert-butyloxycarbonyl Glutathione Dimethyl Diester, CAS: /, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃N₃O₉S.
S-(2-Hydroxyethyl)-N-tert-butyloxycarbonyl Glutathione-d4, CAS: /, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅D₄N₃O₉S.
S-(2-Hydroxyethyl)-N-tert-butyloxycarbonyl Glutathione-d4 Dimethyl Diester, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉D₄N₃O₉S.
S-(2-Hydroxyethyl)glutathione, CAS: 28747-20-8, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₃O₇S.
S-(2-Hydroxyethyl)glutathione Hydrochloride, CAS: 1356019-55-0, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂ClN₃O₇S.
S-(2-Hydroxyethyl)glutathione-d4 Hydrochloride, CAS: /, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈D₄ClN₃O₇S.
S-(2-Hydroxypropyl)glutathione, CAS: 85933-29-5, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃N₃O₇S.
S-(2-Hydroxypropyl)glutathione-d6, CAS: /, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇D₆N₃O₇S.
S-(Hexamethylcarbamoyl)glutathione, CAS: 116430-63-8, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈N₄O₇S.
S-(α-Methylcarboxymethyl)glutathione Ethyl Ester, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅N₃O₈S.
S-(α-Methylcarboxymethyl)glutathione-d4 Methyl Ester, CAS: /, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₄N₃O₈S.
S-(N,N-Diethylcarbamoyl)glutathione, CAS: 157723-51-8, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₄O₇S.
S-(N-Methylcarbamoyl)glutathione, CAS: 38126-73-7, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₄O₇S.
S-(N-Methylcarbamoyl)glutathione-d3, CAS: 127633-23-2, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇D₃N₄O₇S.
S-(p-Azidophenacyl)glutathione, CAS: 73322-71-1, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₆O₇S.
S-Benzyl Thiorphan, CAS: /, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₃S.
S-Desethylpiperidino S-(Glycin-N-yl) Vardenafil, CAS: 448184-54-1, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₅O₆S.
S-Ethylglutathione, CAS: 24425-52-3, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₃O₆S.
S-Methyl Tiopronin, CAS: 87254-91-9, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃S.
S-Methylglutathione, CAS: 2922-56-7, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉N₃O₆S.
S-Nitroso-L-glutathione, CAS: 57564-91-7, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₇S.
S-[2-(N7-Guanyl)ethyl]glutathione, CAS: 100840-34-4, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₈O₇S.
S-[2-(N7-Guanyl)ethyl]glutathione-d4, CAS: 220317-14-6, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₄N₈O₇S.
S-[2-Hydroxy-1-(4-hydroxyphenyl)ethyl]-L-glutathione, CAS: 1309781-40-5, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₈S.
S-[2-Hydroxy-1-(4-hydroxyphenyl)ethyl]-L-glutathione-13C,d2, CAS: /, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₂₃D₂N₃O₈S.
S-[2-Hydroxy-2-(4-hydroxyphenyl)ethyl]-L-glutathione, CAS: 1309781-36-9, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₈S.
S-[2-Hydroxy-2-(4-hydroxyphenyl)ethyl]-L-glutathione-13C2,d, CAS: /, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₂H₂₄DN₃O₈S.
Sarcosine, CAS: 107-97-1, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇NO₂.
Sarcosine Ethyl Ester Hydrochloride, CAS: 52605-49-9, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.
Sarcosine Sodium Salt, CAS: 4316-73-8, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆NNaO₂.
Sarcosine Sodium Salt-13C3, CAS: /, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₆NNaO₂.
Sarcosine-13C, CAS: /, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³CH₇NO₂.
Sarcosine-13C3, CAS: /, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₇NO₂.
Sarcosine-d3 Hydrochloride, CAS: 347840-04-4, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅D₃ClNO₂.
Shikimate-3-phosphate Trisodium Salt (90%), CAS: 143393-03-7, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈Na₃O₈P.
Sinorphan, CAS: 112573-73-6, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄S.
Sinorphan-d5, CAS: /, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₅NO₄S.
Sivelestat Sodium, CAS: 150374-95-1, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₂NaO₇S.
Sodium N-Decanoylsarcosinate, CAS: 30377-07-2, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄NNaO₃.
Sodium N-Decanoylsarcosinate-d19, CAS: /, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₅D₁₉NNaO₃.
Sodium N-Myristoylsarcosinate, CAS: 30364-51-3, stock: 3.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₂NNaO₃.
Stepronin, CAS: 72324-18-6, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄S₂.
Suberyl Glycine, CAS: 60317-54-6, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₅.
Suberyl Glycine-13C2,15N, CAS: /, stock: 1.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₇¹⁵NO₅.
Suberyl Glycine-d4, CAS: /, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₄NO₅.
Sulfosate, CAS: 81591-81-3, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆NO₅PS.
Tanogitran Dihydrochloride, CAS: 253796-69-9, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃Cl₂N₇O₃.
Teduglutide Trifluoroacetic Acid Salt, CAS: /, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆₄H₂₅₂N₄₄O₅₅S • (C  ₂HF₃O₂).
Teduglutide-d8 (Phe-d8), CAS: /, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆₄H₂₄₄D₈N₄₄O₅₅S.
Teduglutide-d8 TFA salt x hydrate (Leu-methyl-d3+Phe-d5), CAS: /, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆₄H₂₄₄D₈N₄₄O₅₅S  •  C₂HF₃O₂  • x( H₂O).
tert-​Butyl (4-​Fluoro-​4-​piperidinyl)​methylcarbamate, CAS: 871022-62-7, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁FN₂O₂.
tert-​Butyl 2-​Amino-​2-​thioxoethylcarbamate, CAS: 89226-13-1, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₂S.
tert-Butyl (2-(Methoxy(methyl)amino)-2-oxoethyl)carbamate, CAS: 121505-93-9, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₄.
tert-Butyl 2-(Benzylamino)acetate, CAS: 7662-76-2, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.
tert-Butyl 2-[4-(2-Fluorophenyl)-6-methylthieno[2,3-d]pyrimidin-2-ylamino]acetate, CAS: 1076199-69-3, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀FN₃O₂S.
tert-Butyl N-Methylaminoacetate Hydrochloride, CAS: 136088-69-2, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂•HCl.
Thiamphenicol Glycinate Hydrochloride, CAS: 2611-61-2, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈Cl₂N₂O₆S •   (HCl).
Thiorphan, CAS: 76721-89-6, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃S.
Thiorphan Disulfide, CAS: 123658-06-0, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₆S₂.
Thiorphan-d5, CAS: /, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₅NO₃S.
Thiorphan-d7, CAS: 1276297-68-7, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈D₇NO₃S.
Tiglyl Glycine, CAS: 35842-45-6, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.
Tiglyl Glycine Methyl Ester, CAS: 55649-53-1, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.
Tiglyl Glycine-13C2,15N, CAS: /, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₁₁¹⁵NO₃.
Tiglyl Glycine-13C2,15N Methyl Ester, CAS: /, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₃¹⁵NO₃.
Tiopronin, CAS: 02/02/1953, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₃S.
Tiopronin Disulfide, CAS: 21269-37-4, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₆S₂.
Tiopronin-13C,d3, CAS: 1189695-13-3, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₆D₃NO₃S.
Tiopronin-d3, CAS: 1189700-74-0, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆D₃NO₃S.
Tolrestat, CAS: 82964-04-3, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃NO₃S.
Tolrestat-d3, CAS: /, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃F₃NO₃S.
trans-1,2-Diaminocyclohexane-N,N,N’,N’-tetraacetic Acid Monohydrate, CAS: 125572-95-4, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₂O₉.
Tricine, CAS: 01/04/5704, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₅.
Tridecyl 2-Aminoacetate Hydrochloride, CAS: 94856-88-9, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂ClNO₂.
Vadadustat, CAS: 1000025-07-9, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClN₂O₄.
Vinylacetic Acid, CAS: 625-38-7, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₂.
VU0029767, CAS: 326001-01-8, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₃O₃.
Ximelagatran, CAS: 192939-46-1, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅N₅O₅.
Ximelagatran Nitrile, CAS: 260790-61-2, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₄O₄.
Ximelagatran Nitrile-d11, CAS: /, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₁₁N₄O₄.
Ximelagatran-d11, CAS: /, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄D₁₁N₅O₅.
Z-α-Phosphonoglycine, CAS: 88568-95-0, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈NO₇P.
Z-L-Neopentylglycine Dicyclohexylammonium Salt, CAS: 88319-45-3, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄N₂O₄.
Z-L-Phenylglycine, CAS: 53990-33-3, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄.
Zinc Glycinate, CAS: 06/08/7214, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O₄Zn.
[2-(Oxiranyl)ethyl]triphenylphosphonium Iodide, CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂IOP.
[D-Trp8]-gamma-MSH, CAS: 321351-81-9, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₄H₉₉N₂₁O₁₆S.
[Sar-9, Met(O2)-11]-substance P, CAS: 110880-55-2, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₄H₁₀₀N₁₈O₁₅S.
1,4,7,10-Tetraaza-1,4,7-tris-(carboxymethyl)-11-oxo-bicyclo[8.2.2]tetradecanium Halide salt, CAS: /, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  [C₁₆H₂₇N₄O₇] Base Molecule.
1,4,7,10-Tetraazacyclododecane--4-formyl-1,7-diacetic Acid, CAS: /, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄N₄O₅.
1,4,7,10-Tetraazacyclododecane-1,7-diacetic Acid, CAS: 112193-75-6, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₄O₄.
1,4,7,10-Tetraazacyclododecane-1-carboxaldehyde, CAS: 120041-13-6, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₄O.
1,​4,​7,​10-​Tetraazabicyclo[8.2.​2]​tetradecan-​11-​one, CAS: 220182-11-6, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₄O.
11-Oxo-1,4,7,10-tetraazabicyclo[8.2.2]tetradecane-4,7-diacetic Acid, CAS: 220182-19-4, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₄O₅.
13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid, CAS: 229312-33-8, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₅.
13-Oxo-1,4,7,10-tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid Dimethyl Ester, CAS: /, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₄O₅.
2a,4a,6a,8a-Decahydrotetraazacyclopent[fg]acenaphthylene, CAS: 74199-09-0, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₄.
Des(2-Hydroxypropyl) Gadoteridol, CAS: 112188-16-6, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃GdN₄O₆.
Desgadolinium Gadoteridol, CAS: 120041-08-9, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₄O₇.
Gadoteridol, CAS: 120066-54-8, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉GdN₄O₇.
[1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-κN1,κN4,κN7,κN10,κO1,κO4,κO7,κO10]-gadolinate(1-) Sodium, CAS: 92923-44-9, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄GdN₄NaO₈.
Gadopentetic Acid, CAS: 80529-93-7, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈GdN₃O₁₀  •2H.
2,2’-(4,10-bis(1,3,4-Trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic Acid Tetrahydrochloride, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₄₀N₄O₁₀·4(HCl).
Gadobutrol, CAS: 770691-21-9, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁GdN₄O₉.
Gadobenic Acid Disodium Salt, CAS: 113662-22-9, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄GdN₃Na₂O₁₁.
1,1-Cyclohexanediacetic Acid Monoamide, CAS: 99189-60-3, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃.
1-(2-Aminoethyl)-cyclohexaneacetic Acid Acetic Acid Salt, CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.
1-(3-Oxo-2-aza-spiro[4,5]dec-2-ylmethyl)cyclohexaneethanol, CAS: 1797133-25-5, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₂.
1-(Isobutyryloxy) Ethyl 3-Oxo-2-azaspiro[4,5]decane-2-carboxylate, CAS: /, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₅.
1-(Nitromethyl)cyclohexane-d6-acetic Acid Ethyl Ester, CAS: /, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₆NO₄.
1-(Nitromethyl)cyclohexaneacetic Acid Ethyl Ester, CAS: 133938-45-1, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₄.
1-(Nitromethyl)cyclohexaneacetic Acid-d4 Methyl Ester, CAS: 1246815-71-3, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₄NO₄.
1-[[(2-Methyl-1-oxopropyl)amino]methyl]cyclohexaneacetic Acid, CAS: 1281568-83-9, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₃.
2-(3-Oxobutyl)-2-azaspiro[4.5]decan-3-one, CAS: /, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO₂.
2-(3-Oxobutyl)-2-azaspiro[4.5]decan-3-one-d6, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₆NO₂.
2-​((Cyclohexanecarbony​l)​oxy)​acetic Acid, CAS: 667465-00-1, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₄.
2-[1-({[(Benzyloxy)carbonyl]amino}methyl)cyclohexyl]acetic Acid, CAS: 1083246-73-4, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₄.
3,3-Pentamethylene Glutarimide, CAS: 1130-32-1, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂.
4-(2-Methylpropyl)piperidine-2,6-dione, CAS: 916982-10-0, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₂.
ABT 594 Hydrochloride, CAS: 203564-54-9, stock: 6.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClN₂O  • (HCl).
Gabapentin, CAS: 60142-96-3, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.
Gabapentin (1.0 mg/mL in Methanol), CAS: 60142-96-3, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.
Gabapentin 2-Hydroxypropyl Ester, CAS: /, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₃.
Gabapentin Enacarbil Sodium Salt, CAS: 912486-72-7, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NNaO₆.
Gabapentin Enacarbil-d6 Sodium Salt, CAS: /, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁D₆NO₆.
Gabapentin Ethyl Ester Hydrochloride, CAS: 60175-04-4, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₂.
Gabapentin Lactam-d6, CAS: /, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉D₆NO.
Gabapentin Related Bis-nitrile, CAS: 4172-99-0, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.
Gabapentin Related Compound A, CAS: 64744-50-9, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO.
Gabapentin Related Compound B, CAS: 133481-09-1, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₂.
Gabapentin Related Compound D, CAS: 1076198-17-8, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₃.
Gabapentin Related Compound E, CAS: 67950-95-2, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₄.
Gabapentin-d4, CAS: 1185039-20-6, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₄NO₂.
Gabapentin-d4 (100 μg/mL in Methanol), CAS: 1185039-20-6, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₄NO₂.
Gabapentin-d6, CAS: 1346600-67-6, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₆NO₂.
Gabapentin-d6 Hydrochloride, CAS: 1432061-73-8, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂D₆ClNO₂.
Methyl Gabapentin Ester, CAS: 138799-98-1, stock: 3.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₂.
N-rt-Butyloxycarbonyl Gabapentin, CAS: 227626-60-0, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.
1,2,3,4-Tetra-O-acetyl-D-xylopyranose, CAS: 62929-49-1, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₉.
2,5-Diformylfuran, CAS: 823-82-5, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.
2-​(2-​Furylmethylidene)​hydrazine-​1-​carbothioamide, CAS: 5419-96-5, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃OS.
2-Thiophenecarboxaldehyde, CAS: 98-03-3, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄OS.
3-(5-Nitrofurfurylideneamino)hydantoic Acid, CAS: 63981-22-6, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₄O₆.
3-Aminohydantoic Acid, CAS: 138-07-8, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇N₃O₃.
3-Furaldehyde, CAS: 498-60-2, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄O₂.
5-(4-Chlorophenyl)furfural, CAS: 34035-03-5, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇ClO₂.
5-(4-Methoxyphenyl)-2-furancarboxaldehyde, CAS: 34070-33-2, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₃.
5-(4-Nitrophenyl)furfural, CAS: 7147-77-5, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇NO₄.
5-(4-Nitrophenyl)furfural-d4, CAS: /, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₃D₄NO₄.
5-(Bromomethyl)furan-2-carboxaldehyde, CAS: 39131-44-7, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrO₂.
5-(Chloromethyl)furfural, CAS: 1623-88-7, stock: 3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClO₂.
5-Acetoxymethyl-2-furaldehyde, CAS: 10551-58-3, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.
5-Acetoxymethyl-2-furaldehyde-13C6, CAS: 1215731-50-2, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₈O₄.
5-Bromofuran-2-carboxaldehyde, CAS: 1899-24-7, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrO₂.
5-Deoxy-D-xylose, CAS: 13039-77-5, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄.
5-Formylfuran-2-carboxylic Acid, CAS: 13529-17-4, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄O₄.
5-Hydroxymethyl-2-furaldehyde, CAS: 67-47-0, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.
5-Hydroxymethyl-2-furaldehyde (0.001mg/mL in Acetonitrile), CAS: 67-47-0, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.
5-Hydroxymethyl-2-furaldehyde-13C6, CAS: 1219193-98-2, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₆O₃.
5-Hydroxymethyl-2-furoylglycine, CAS: 38716-68-6, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₅.
5-Hydroxymethyl-2-furoylglycine-13C2,15N, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₉¹⁵NO₅.
5-Hydroxymethyl-2-furoylglycine-13C6, CAS: /, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₉NO₅.
5-Methylfurfural, CAS: 620-02-0, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₂.
5-Methylfurfural in 1mg/L in Acetonitrile, CAS: 620-02-0, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₂.
5-Nitro-2-furaldehyde, CAS: 698-63-5, stock: 3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃NO₄.
5-Nitro-2-furaldoxime, CAS: 555-15-7, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₄.
5-Nitro-2-furfuraldazine, CAS: 112537-96-9, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₄O₆.
5-Sulfooxymethylfurfural Sodium Salt, CAS: 1330171-28-2, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NaO₆S.
5-Sulfooxymethylfurfural-13C6 Sodium Salt, CAS: 1329613-50-4, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₅NaO₆S.
D-Xylose, CAS: 58-86-6, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₅.
D-Xylose-1,2,3,4,5,5’-C-d6, CAS: /, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₆O₅.
D-Xylose-1-C-d, CAS: 288846-89-9, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉DO₅.
D-Xylose-2-C-d, CAS: 288846-91-3, stock: 8.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉DO₅.
D-Xylose-5-C-d2, CAS: /, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉DO₅.
D-[1,2-13C2]Xylose, CAS: 201741-00-6, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₁₀O₅.
D-[1-13C]Xylose, CAS: 70849-21-7, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
D-[13C5]Xylose, CAS: 1262683-58-8, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₀O₅.
D-[2-13C]Xylose, CAS: 131771-69-2, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
D-[3-13C]Xylose, CAS: /, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
D-[4-13C]Xylose, CAS: /, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
D-[5-13C]Xylose, CAS: 139657-63-9, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₀O₅.
Furfural, CAS: 98-01-1, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄O₂.
Furfural (1mg/L in Acetonitrile), CAS: 98-01-1, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄O₂.
Furfural-d4 (Stabilized with BHT), CAS: 1219803-80-1, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₄O₂.
Furfuraldoxime, CAS: 1450-58-4, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₂.
Furfuryl Alcohol, CAS: 98-00-0, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₂.
Furfuryl Alcohol (1mg/L in acetonitrile), CAS: 98-00-0, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₂.
Furfuryl Alcohol-d2, CAS: 109930-25-8, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₂O₂.
Methyl 2-(5-(Acetoxymethyl)furan-2-carboxamido)acetate, CAS: /, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₆.
Methyl 2-(5-(Acetoxymethyl)furan-2-carboxamido)acetate-13C2,15N, CAS: /, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₂H₁₃¹⁵NO₆.
Tetrachlorohafnium, CAS: 13499-05-3, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₄Hf.
Tricyclohexylphosphonium Tetrafluoroborate, CAS: 58656-04-5, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃P • BF  ₄•H.
Trimethoxysilane, CAS: 2487-90-3, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀O₃Si.
Triruthenium Dodecacarbonyl, CAS: 15243-33-1, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂O₁₂Ru₃.
2-NP-AOZ, CAS: 19687-73-1, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₄.
2-NP-AOZ-d4, CAS: 1007478-57-0, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₄N₃O₄.
2-Oxazolidinone, CAS: 497-25-6, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅NO₂.
3-Amino-2-oxazolidinone, CAS: 80-65-9, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆N₂O₂.
3-Amino-2-oxazolidinone-d4, CAS: 1188331-23-8, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₄N₂O₂.
Furazolidone, CAS: 67-45-8, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₅.
Furazolidone-d4, CAS: 1217222-76-8, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃D₄N₃O₅.
Fumonisin B1, CAS: 116355-83-0, stock: 4.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₉NO₁₅.
Fumonisin B1-13C34 solution(25 μg/mL in acetonitrile: water), CAS: 1217458-62-2, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃₄H₅₉NO₁₅.
Fumonisin B1-13C4, CAS: 1324564-22-8, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀¹³C₄H₅₉NO₁₅.
Fumonisin B3, CAS: 1422359-85-0, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₉NO₁₄.
Hydrolyzed Fumonisin B1, CAS: 145040-09-1, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₇NO₅.
Hydrolyzed Fumonisin B2, CAS: 147985-10-2, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₇NO₄.
(17β)-3,17-Bis-O-[(tetrahydro-2H-pyran-2-yl)-6-O-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl-estra-1,3,5(10),6(7)-tetraene, CAS: /, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₁F₅O₅S.
(S,S,S)-(3,5-Dioxa-4-phosphacyclohepa[2,1-a:3,4-a’]dinaphthalen-4-yl)bis(1-phenylethyl)amine, CAS: 209482-27-9, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀NO₂P.
1-Bromo-9-(tert-butyldimethylsilyloxy)nonane, CAS: 149051-24-1, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₃BrOSi.
3-O-Benzyl Fulvestrant, CAS: /, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₃F₅O₃S.
3-O-Methyl Fulvestrant, CAS: 1221256-46-7, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₉F₅O₃S.
4,4,5,5,5-Pentafluoro-1-pentanethiol, CAS: 148757-88-4, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇F₅S.
6-Keto Fulvestrant, CAS: /, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₅O₄S.
7,7’-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17β-diol](Mixture of Diastereomers), CAS: /, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₄O₄.
7,7’-Nonane-1,9-diylbis[estra-1,3,5(10)-triene-3,17β-diol] Tetraacetate, CAS: /, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₇₂O₈.
7-[9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17β-diol (Mixture of Diastereomers), CAS: /, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₅F₅O₄S₂.
7β-Acetyloxy-7α-[9-(dimethyl(tert-butylsilyloxy)nonyl]estr-4-en-3-one, CAS: 875573-60-7, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₀O₄Si.
7β-Fulvestrant, CAS: 407577-53-1, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₇F₅O₃S.
7β-Fulvestrant-d4, CAS: /, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃D₄F₅O₃S.
7β-[9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl]estra-4-ene-3,17β-diol 17-Acetate, CAS: /, stock: 9.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₉F₅O₃S₂.
9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonanol, CAS: 1391053-10-3, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₅F₅OS₂.
9-[[9-[(4,4,5,5,5-Pentafluoropentyl)sulfenyl]nonyl]sulfenyl]nonyl Bromide, CAS: 1391053-14-7, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₂BrF₅S₂.
∆6-Fulvestrant, CAS: /, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₅O₃S.
Carbamimidothioic Acid 9-Hydroxynonyl Ester Bromide, CAS: 511545-93-0, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₃BrN₂OS.
Fulvestrant, CAS: 129453-61-8, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₇F₅O₃S.
Fulvestrant 17-β-D-Glucuronide, CAS: 261506-28-9, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₅F₅O₉S.
Fulvestrant 17-Ketone, CAS: 403656-89-3, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₅O₃S.
Fulvestrant 3-β-D-Glucuronide, CAS: 261506-27-8, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₅F₅O₉S.
Fulvestrant 3-β-D-Glucuronide 17-Acetate, CAS: 403656-84-8, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₆₅F₅O₁₃S.
Fulvestrant 3-Sulfate Sodium Salt, CAS: 403656-83-7, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆F₅NaO₆S₂.
Fulvestrant 9-Sulfone, CAS: 98008-06-1, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₇F₅O₄S.
Fulvestrant-d3, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄D₃F₅O₃S.
Fulvestrant-d4, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₃D₄F₅O₃S.
Non-8-enyl Bromide, CAS: 89359-54-6, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇Br.
S-Deoxo ∆6-Fulvestrant, CAS: /, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₅O₂S.
S-Deoxo-3,17-bis-(O-tetrahydro-2H-pyran-2-yl)-6-hydroxy-fulvestrant, CAS: /, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₃F₅O₅S.
S-Deoxo-3,17β-bis-(O-tetrahydro-2H-pyran-2-yl)-6-oxo-fulvestrant, CAS: 862700-70-7, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₁F₅O₅S.
S-Deoxo-6-oxo-fulvestrant, CAS: 1107606-70-1, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₅O₃S.
AB-CHMINACA (1.0 mg/mL in Methanol), CAS: 1185887-21-1, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₄O₂.
AB-CHMINACA 2’-Indazole Isomer RM, CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₄O₂.
AB-CHMINACA Metabolite M1A, CAS: /, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₄O₃.
AB-CHMINACA Metabolite M1B, CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₄O₃.
AB-CHMINACA metabolite M2, CAS: 1185887-51-7, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇N₃O₃.
AB-CHMINACA Metabolite M2 Methyl Ester, CAS: 1971007-96-1, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₃.
AB-CHMINACA metabolite M3A, CAS: /, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇N₃O₄.
AB-CHMINACA metabolite M5A, CAS: /, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₃.
AB-CHMINACA metabolite M7, CAS: /, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₅.
AB-FUBINACA Isomer 5, CAS: /, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₄O₂.
ADB-FUBINACA (1.0 mg/mL in Methanol), CAS: 1445583-51-6, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃FN₄O₂.
APP-FUBINACA RM, CAS: 1185282-03-4, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₄N₄O₂.
Cumyl-THPINACA RM, CAS: 1400742-50-8, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₃O₂.
FU-AEB (1.0 mg/mL in Methanol), CAS: /, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄FN₃O₃.
FUB-APINACA, CAS: /, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆FN₃O.
L-ADB-CHMINACA, CAS: 1185887-13-1, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀N₄O₂.
MAB-CHMINACA Metabolite M10, CAS: /, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₃O₃.
MAB-CHMINACA Metabolite M3, CAS: /, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₃O₄.
MAB-CHMINACA Metabolite M7, CAS: /, stock: 5.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇N₃O₅.
MDMB-FUBINACA, CAS: /, stock: 9.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄FN₃O₃.
MMB-Fubinaca, CAS: 1971007-92-7, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂FN₃O₃.
N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide (100 µg/mL in Methanol), CAS: 1185282-01-2, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁FN₄O₂.
N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, CAS: 1863065-92-2, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀N₄O₂.
1-(R)-Hydroxy Frovatriptan, CAS: /, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₂.
1-(S)-Hydroxy Frovatriptan, CAS: /, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₂.
3R-6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole, CAS: 247939-84-0, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.
3S-6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole, CAS: 1217755-82-2, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.
4-Hydroxy-frovatriptan, CAS: /, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₂.
ent-Frovatriptan, CAS: 158930-18-8, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O.
Frovatriptan Succinate Monohydrate, CAS: 158930-17-7, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₆.
rac Frovatriptan-d3 Succinate Monohydrate (2:1:1), CAS: /, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₆D₆N₆O₇.
rac-4-Keto Frovatriptan, CAS: /, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₂.
rac-6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole, CAS: 147009-33-4, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.
rac-6-Cyano-3-N-methylamino-1,2,3,4-tetrahydrocarbazole-d3, CAS: 1794979-58-0, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₃N₃.
rac-6-Deaminocarbonyl-frovatriptan-5-carboxamide, CAS: /, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O.
rac-6-Deaminocarbonyl-frovatriptan-5-carboxamide-d3, CAS: /, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₃N₃O.
rac-6-Deaminocarbonyl-frovatriptan-7-carboxamide, CAS: /, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O.
rac-6-Deaminocarbonyl-frovatriptan-7-carboxamide-d3, CAS: /, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₃N₃O.
rac-6-Deaminocarbonyl-frovatriptan-8-carboxamide, CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O.
rac-6-Deaminocarbonyl-frovatriptan-8-carboxamide-d3, CAS: /, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₃N₃O.
rac-Frovatriptan Acid, CAS: /, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₂.
rac-Frovatriptan Acid-d3, CAS: /, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₃N₂O₂.
rac-N-Methyl-frovatriptan Oxalate, CAS: 214917-60-9, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₅.
rac-N-Methyl-frovatriptan-d6 Oxalate, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₆N₃O₅.
((4S)-4-Cyclohexyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-D-proline Propionate (Ester) Hemibarium Salt Sesquihydrate), CAS: /, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆NO₇P • 0.5Ba • 1.5H  ₂O.
(2R,4S)-Fosinopril Sodium Salt, CAS: 1356932-15-4, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅NNaO₇P.
(2S,4R)-1-(tert-Butoxycarbonyl)-4-(tosyloxy)pyrrolidine-2-carboxylic Acid, CAS: 96314-28-2, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₇S.
(2S,4R)-Fosinopril Sodium Salt, CAS: 1356353-41-7, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅NNaO₇P.
(2S,4S)-4-Cyclohexyl-1-(3-oxopentanoyl)pyrrolidine-2-carboxylic Acid, CAS: 149760-14-5, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₄.
(4-Phenylbutyl)phosphinyl Acetic Acid Disodium Salt, CAS: /, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅Na₂O₄P.
(4S)-4-Cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline Propionate (Ester) Sodium Salt (Mixture), CAS: 1217528-56-7, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅NNaO₇P.
(4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-Proline Phenylmethyl Ester, CAS: 474382-58-6, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀NO₅P.
(4S)-4-Cyclohexyl-L-proline Hydrochloride, CAS: 90657-55-9, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀ClNO₂.
(4S)-4-Cyclohexyl-L-proline Phenylmethyl Ester Hydrochloride, CAS: 474382-57-5, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₂ •HCl.
1-(1-Oxopropyl)-(4S)-4-cyclohexyl-L-proline, CAS: 1421283-57-9, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₃.
1-Chloroisobutyl propionate (Technical Grade), CAS: 58304-65-7, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃ClO₂.
4-Hydroxy Fosinoprilat, CAS: 113411-10-2, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄NO₆P.
4-Phenybutyl 2-Carboxyethylphosphinic Acid (Fosinopril Impurity), CAS: 83623-61-4, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇O₄P.
4-Phenylbutylphosphonic Acid, CAS: 46348-61-2, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅O₃P.
Benzyl Hydroxy(4-phenylbutyl)phosphinoacetate, CAS: 87460-09-1, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃O₄P.
Boc-trans-Hydroxy-L-proline, CAS: 13726-69-7, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₅.
Dehydro Fosinopril Sodium Salt, CAS: /, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₉NNaO₇P.
Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid, CAS: 128948-00-5, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉O₆P.
Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid-d7, CAS: /, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₇O₆P.
Desmethyl Fosinopril Sodium Salt, CAS: /, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₃NNaO₇P.
Fosinopril Acyl-β-D-Glucuronide, CAS: /, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₄NO₁₃P.
Fosinopril Sodium Salt, CAS: 88889-14-9, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅NNaO₇P.
Fosinopril-d5, CAS: 98048-97-6, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₁D₅NO₇P.
Fosinopril-d5 Cesium, CAS: /, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀D₅CsNO₇P.
Fosinopril-d5 Sodium Salt, CAS: 1217513-43-3, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀D₅NNaO₇P.
Fosinopril-d5 Sodium Salt, CAS: /, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₀D₅NNaO₇P.
Fosinoprilat, CAS: 95399-71-6, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄NO₅P.
Fosinoprilat Acyl-β-D-Glucuronide, CAS: 113411-09-9, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₂NO₁₁P.
Fosinoprilat Disodium Salt, CAS: /, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂NNa₂O₅P.
Fosinoprilat-d5 Sodium Salt, CAS: 1217522-63-8, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈D₅NNaO₇P.
Fosinoprilat-d7, CAS: 1279220-43-7, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇D₇NO₅P.
Methylphenyl Fosinopril-d5, CAS: /, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₇D₅NO₇P.
rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid(Mixture of Diastereomers), CAS: 123599-78-0, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉O₆P.
rac-Des(4-cyclohexyl-L-proline) Fosinopril Acetic Acid-d7, CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₇O₆P.
(1-Hydroxy-2-(1,2-dihydroxypropyl)phosphonyl)propylphosphonic Acid, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆O₉P₂.
(1R,2R)-1-(Bis(benzyloxy)phosphoryl)-1-hydroxypropan-2-yl Hydrogen (1-Bromo-2-hydroxypropyl)phosphonate, CAS: /, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇BrO₈P₂.
(2-Fosfomycinyl-1-(hydroxy)propyl)phosphonic Acid, CAS: 1416734-33-2, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₈P₂.
1-(Dimethoxyphosphoryl)-1-phenoxypropan-2-yl-1-(benzyloxy) Methanesulfonate, CAS: /, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁O₇PS.
2-Amino-3-hydroxy-2-(hydroxymethyl)propyl Phosphate Barium Salt, CAS: 114252-50-5, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀BaNO₆P.
2-Benzyloxyethyl Phosphate Dibenzyl Ester, CAS: 1798042-79-1, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅O₅P.
2-Ethoxyethanol 1-(Dihydrogen Phosphate) Sodium Salt (1:2), CAS: 1229236-93-4, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉Na₂O₅P.
2-Hydroxyethanephosphonic Acid, CAS: 22987-21-9, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₇O₄P.
2-Hydroxyethanephosphonic Acid-d4, CAS: /, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃D₄O₄P.
Benzyl (5-(((Bis(benzyloxy)phosphoryl)oxy)methyl)-2-phenyl-1,3-dioxan-5-yl)carbamic Acid Ester, CAS: /, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₄NO₈P.
Benzyl(1,3-bis((1-(bis(benzyloxy)phosphoryl)-1-hydroxypropan-2-yl)oxy)-2-(hydroxymethyl)propan-2-yl)carbamate, CAS: /, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₅₅NO₁₃P₂.
Benzyl-(1-((1-(bis(benzyloxy)phosphoryl)-1-hydroxypropan-2-yl)oxy)-3-hydroxy-2-(hydroxymethyl)propan-2-yl)carbamate, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₆NO₉P.
cis-(3-Methyloxiranyl)phosphonic Acid  Bis(phenylmethyl) Ester, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉O₄P.
cis-Propenylphosphonic Acid-13C3, CAS: /, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₃H₇O₃P.
Diethyl (2-hydroxyethyl)phosphonate, CAS: 39997-40-5, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅O₄P.
Fosfomycin Disodium Salt, CAS: 26016-99-9, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅Na₂O₄P.
Fosfomycin Phenylethylamine, CAS: 25383-07-7, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N  •  C₃H₇O₄P.
Fosfomycin Sodium, CAS: 23155-02-4, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇O₄P.
Fosfomycin Trometamol Impurity A, CAS: /, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂₀NO₈P.
N,N’-Dicyclohexyl-carbamimidic Acid Phenylmethyl Ester, CAS: 6738-17-6, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O.
N-[5-(Hydroxymethyl)-2-phenyl-1,3-dioxan-5-yl]-carbamic Acid Benzyl Ester, CAS: 1125824-87-4, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₅.
N-[5-[((Methylsulfonyl)oxy)methyl]-2-phenyl-1,3-dioxan-5-yl]carbamic Acid Phenylmethyl Ester, CAS: /, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₇S.
P-[(1R,2R)-1,2-Dihydroxypropyl]-phosphonic Acid Ammonium Salt, CAS: 1160525-87-0, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉O₅P  • x(NH ₃).
P-[(1R,2R)-1,2-Dihydroxypropyl]phosphonic Acid Bis(phenylmethyl) Ester, CAS: /, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁O₅P.
P-[(1R,2R)-2-Hydroxy-1-[[(4-methylphenyl)sulfonyl]oxy]propyl]phosphonic Acid Bis(phenylmethyl) Ester, CAS: /, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇O₇PS.
P-[2-Hydroxy-1-(phenylmethoxy)propyl]phosphonic Acid Dimethyl Ester, CAS: /, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉O₅P.
P-[2-Oxo-1-(phenylmethoxy)propyl]phosphonic Acid Dimethyl Ester, CAS: 1258067-56-9, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇O₅P.
[2-[2-Amino-3-hydroxy-2-(hydroxymethyl)propoxy]-1-hydroxypropyl]phosphonic Acid, >90%, CAS: 1262243-11-7, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₈NO₇P.
[R-(R*,R*)]-(1,2-Dihydroxypropyl)phosphonic Acid, CAS: 132125-60-1, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉O₅P.
3-O-Octadecyl sn-Glycerol, CAS: 10567-22-3, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₄O₃.
3-O-Octadecyl sn-Glycerol-d5, CAS: /, stock: 3.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₉D₅O₃.
Diethyl (Ethoxycarbonyl)phosphonate, CAS: 1474-78-8, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅O₅P.
Disodium (Ethyl phosphono)formate, CAS: 55920-24-6, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇O₅P • 2Na.
Disodium Ethoxyoxidophosphanyl)formate, CAS: /, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅Na₂O₄P.
Foscarnet Sodium, CAS: 63585-09-1, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CNa₃O₅P.
Foscarnet Sodium Hexahydrate, CAS: 34156-56-4, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₁₂Na₃O₁₁P.
(2-(((2-Phenyl-1-(4-(trifluoromethyl)phenyl)ethylidene)amino)oxy)ethyl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₃N₂O₃.
(E)-(2-((tert-Butoxycarbonyl)amino)ethyl)(2-(((1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀F₃N₃O₅.
(E)-1-(4-(Trifluoromethyl)phenyl)ethanone O-(2-Aminoethyl) Oxime Maleate, CAS: /, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃F₃N₂O • (C  ₄H₄O₄).
(E)-1-(4-(Trifluoromethyl)phenyl)pentan-1-one Oxime, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄F₃NO.
(E)-2-Phenyl-1-(4-(trifluoromethyl)phenyl)ethanone Oxime, CAS: /, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂F₃NO.
(E)-Fluvoxamine Maleate, CAS: 61718-82-9, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅F₃N₂O₆.
(E)-Fluvoxamine-d3 Maleate, CAS: 1185245-56-0, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂D₃F₃N₂O₆.
(E)-Fluvoxamine-d4 Maleate, CAS: 1432075-74-5, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₄F₃N₂O₆.
(Z)-2-Phenyl-1-(4-(trifluoromethyl)phenyl)ethanone Oxime, CAS: /, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂F₃NO.
(Z)-Fluvoxamine, CAS: 917096-37-8, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁F₃N₂O₂.
2-Aminoethoxy-d4-amine Dihydrochloride, CAS: /, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆D₄Cl₂N₂O.
2-Phenyl-1-[4-(trifluoromethyl)phenyl]ethane 2-(Aminoethyl)oxime(Fluvoxamine Impurity), CAS: 1217241-15-0, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇F₃N₂O.
4’-(Trifluoromethyl)valerophenone-(E)-O-2-(2-aminoethyl) Oxime Maleate, CAS: /, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈F₃N₃O₅.
5-Methoxy-1-[4-(difluoromethyl)phenyl]-1-pentanone Oxime, CAS: 1391062-36-4, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇F₂NO₂.
5-Methoxy-1-[4-(trifluoromethyl)phenyl]-1-pentanone Oxime(Fluvoxamine Impurity), CAS: 88699-84-7, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆F₃NO₂.
Deaminoethyl Fluvoxamine β-D-Glucuronide, CAS: 89035-93-8, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄F₃NO₈.
Desfluoro Fluvoxamine, CAS: 1217214-94-2, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂F₂N₂O₂.
Desfluoro Fluvoxketone, CAS: 1391053-78-3, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆F₂O₂.
Desmethoxy Fluvoxamine Hydrochloride, CAS: /, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClF₃N₂O.
Desmethoxy N-Boc Fluvoxamine Hydrochloride, CAS: /, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇F₃N₂O₃.
Desmethyl Fluvoxamine, CAS: 192876-02-1, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉F₃N₂O₂.
Desmethyl Fluvoxamine β-D-Glucuronide, CAS: 89103-66-2, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇F₃N₂O₈.
Desmethyl N-Acetyl Fluvoxamine, CAS: /, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁F₃N₂O₃.
Fluvoxamine, CAS: 54739-18-3, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁F₃N₂O₂.
Fluvoxamine Acid, CAS: 88699-91-6, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇F₃N₂O₃.
Fluvoxamine Acid Trifluoroacetic Acid Salt, CAS: /, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈F₆N₂O₅.
Fluvoxamine Maleic Acid Monoamide(Fluvoxamine Maleate Impurity), CAS: /, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃F₃N₂O₅.
Fluvoxketone, CAS: 61718-80-7, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅F₃O₂.
α-​[4-​(Trifluoromethyl)​phenyl]​benzeneethanol, CAS: 136757-49-8, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃F₃O.
N-(2-Bromoethyl-d4)phthalimide, CAS: 1009307-39-4, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₄BrNO₂.
N-(2-Succinyl) Fluvoxamine Bis-methyl Ester, CAS: /, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉F₃N₂O₆.
N-(Ethylamino) Fluvoxamine (up to 15% Z isomer), CAS: 1217262-11-7, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆F₃N₃O₂.
N-(Ethylamino) Fluvoxamine N-Carbamic Acid, CAS: /, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆F₃N₃O₄.
N-Acetyl Fluvoxamine Acid, CAS: 88699-87-0, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₃N₂O₄.
N-​(2-​Bromoethyl)​carbamic Acid 9H-Fluoren-9-ylmethyl Ester, CAS: /, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆BrNO₂.
N-Boc Desmethyl Fluvoxamine, CAS: 192876-03-2, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇F₃N₂O₄.
N-Boc Fluvoxamine Acid, CAS: 1159977-14-6, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅F₃N₂O₅.
N-Boc Fluvoxamine-d3, CAS: 1185235-90-8, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆D₃F₃N₂O₄.
N-Boc-(Ethylamino)-1,1-dimethylethyl Ester Fluvoxamine, CAS: /, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂F₃N₃O₆.
N-Fmoc (E)-Fluvoxamine, CAS: /, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁F₃N₂O₄.
N-Fmoc (Z)-Fluvoxamine, CAS: /, stock: 4.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁F₃N₂O₄.
N-[4-(Trifluoromethyl)benzoyl]glycine, CAS: 89035-91-6, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈F₃NO₃.
(-)-(3S,5R)-Fluvastatin-d7, CAS: /, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₇FNO₄.
(3R,5R,6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid 1,1-Dimethylethyl Ester, CAS: 194934-98-0, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FNO₄.
(3R,5S)-Fluvastatin Sodium Salt, CAS: 94061-80-0, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
(3R,5S)-Fluvastatin tert-Butyl Ester, CAS: 194934-96-8, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FNO₄.
(3R,5S)-Fluvastatin-3,5-acetonide tert-Butyl Ester, CAS: 500731-91-9, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈FNO₄.
(3R,5S)-Fluvastatin-d7 Sodium Salt, CAS: /, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₇FNNaO₄.
(3R,5S)-rel-Fluvastatin-d7 tert-Butyl Ester, CAS: /, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₇FNO₄.
(3S,5R)-Fluvastatin Sodium Salt, CAS: 94061-81-1, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
(3S,5R)-Fluvastatin Sodium Salt-d7, CAS: /, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₇FNNaO₄.
(3S,5R,E)-tert-Butyl Fluvastatin, CAS: 194935-03-0, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FNO₄.
(3S,5S),(3R,5R),(3S,5R),(3R,5S)-Fluvastatin Sodium Salt(mixture of isomers), CAS: /, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
(3S,5S,6E)-O-tert-Butyl Fluvastatin, CAS: 194935-00-7, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FNO₄.
(4S,6R)-6-(Acetoxymethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester, CAS: /, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O₆.
(6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3-hydroxy-5-oxo-6-heptenoic Acid 1,1-Dimethylethyl Ester, CAS: 1379516-02-5, stock: 2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂FNO₄.
(6E)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoic Acid 1,1-Dimethylethyl Ester, CAS: 375846-25-6, stock: 3.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂FNO₄.
(E)-3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)acrylaldehyde, CAS: 93957-50-7, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈FNO.
(E)-3-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)acrylaldehyde-d7, CAS: /, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₁D₇FNO.
(E)-3-[1-Ethyl-3-(4-fluorophenyl)-1H-indol-2-yl]-2-propenal, CAS: 93937-37-2, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆FNO.
(R,R)-Fluvastatin Sodium Salt, CAS: 194934-99-1, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
(S,S)-Fluvastatin Sodium Salt, CAS: 194935-01-8, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
1-Ethyl-3-(4-fluorophenyl)-1H-indole, CAS: /, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄FN.
1-Isopropyl-3-(4-fluorophenyl)indole, CAS: 93957-49-4, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆FN.
1-Isopropyl-3-(4-fluorophenyl)indole-2-carboxaldehyde, CAS: 101125-34-2, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆FNO.
1-Isopropyl-3-(4-fluorophenyl)indole-d7, CAS: /, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₇FN.
3-(4-Fluorophenyl)-1H-indole, CAS: 101125-32-0, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀FN.
3-Amino-α-[[[2-(4-methoxy-3-methylphenyl)-1-methylethyl](phenylmethyl)amino]methyl]-4-(phenylmethoxy)benzenemethanol, CAS: 1616967-24-8, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₂O₃.
3-Keto Fluvastatin N-Ethyl O-tert-Butyl Ester, CAS: /, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀FNO₄.
3-Keto Fluvastatin Sodium Salt, CAS: 1331643-17-4, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃FNNaO₄.
5-Hydroxy Fluvastatin Sodium Salt, CAS: 150767-71-8, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₅.
5-Hydroxy Fluvastatin-d7 Sodium Salt, CAS: /, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₇FNNaO₅.
5-Keto-O-tert-butyl Fluvastatin, CAS: 194935-02-9, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂FNO₄.
5-rac-Fluvastatin O-Methyl 3-Keto, CAS: 110388-33-5, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆FNO₄.
6-[(1E)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]-5,6-dihydro-4-hydroxy-2H-pyran-2-one, CAS: 920275-10-1, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂FNO₃.
Fluvastatin 3-Hydroxy-4,6-diene O-tert-Butyl Ester, CAS: /, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂FNO₃.
Fluvastatin 3-Hydroxy-4,6-diene Sodium Salt, CAS: /, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃FNNaO₃.
Fluvastatin 3-Oxo-4,6-diene O-tert-Butyl Ester, CAS: 920275-08-7, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀FNO₃.
Fluvastatin Lactone, CAS: 94061-83-3, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄FNO₃.
Fluvastatin Methyl Ester, CAS: 93957-53-0, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈FNO₄.
Fluvastatin N-Ethyl O-tert-Butyl Ester, CAS: /, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂FNO₄.
Fluvastatin N-Ethyl Sodium Salt (Fluvastatin Impurity), CAS: 93936-64-2, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃FNNaO₄.
Fluvastatin Sodium Salt(Relative Stereochemistry), CAS: 93957-55-2, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
Fluvastatin-d6 Methyl Ester, CAS: /, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂D₆FNO₄.
Fluvastatin-d6 Sodium Salt, CAS: 93957-55-2, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₆FNNaO₄.
Fluvastatin-d7 Sodium Salt, CAS: 1260178-87-7, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₇FNNaO₄.
α-[[[2-(4-Methoxy-3-methylphenyl)-1-methylethyl](phenylmethyl)amino]methyl]-3-nitro-4-(phenylmethoxy)benzenemethanol, CAS: 1616967-23-7, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆N₂O₅.
N-Benzyl-1-(4-methoxy-3-methylphenyl)propan-2-amine, CAS: /, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO.
N-[5-[1-Hydroxy-2-[[2-(4-methoxy-3-methylphenyl)-1-methylethyl](phenylmethyl)amino]ethyl]-2-(phenylmethoxy)phenyl]-formamide, CAS: 1616967-25-9, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₂O₄.
O-tert-Butyl-3-keto Fluvastatin, CAS: 194934-95-7, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂FNO₄.
rac 5-Keto Fluvastatin, CAS: 1160169-39-0, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄FNO₄.
rac-Fluvastatin Methyl Ester (mixture of diastereomers), CAS: 202479-37-6, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈FNO₄.
rel-(3R,5R)-Fluvastatin Sodium, CAS: 93957-58-5, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FNNaO₄.
tert-Butyl Fluvastatin, CAS: 129332-29-2, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₄FNO₄.
(6α,11β)-6,9-Difluoro-11-((trimethylsilyl)oxy)-17-(1-((trimethylsilyl)oxy)ethylidene)pregna-1,4-diene-3-one-d3, CAS: /, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₁D₃F₂O₃Si₂.
(6α,11β,16α,17α)-(6’α,11’β,16’α,17’α)-17,17’-(Trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-androsta-1,4-dien-3-one, CAS: 960071-64-1, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₈F₄O₁₀S₃.
(6α,11β,16α,17α)-(6’α,11’β,16’α,17’α)-17,17’-(Trithiodicarbonyl)bis[6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-androsta-1,4-dien-3-one-d6, CAS: /, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₂D₆F₄O₁₀S₃.
(9β,11β)-9,11-Epoxy-pregna-1,4,16-triene-20-one-3-O-acetate, CAS: /, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₄.
17α-Trifluoroacetoxyfuticasone 17β-Carboxylic Acid, CAS: /, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅F₅O₆.
21-Carboxylic Acid Fluticasone Dimer Impurity, CAS: /, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₀F₄O₉.
21-Thiocarboxylic Acid Fluticasone Dimer Impurity, CAS: /, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₀F₄O₈S.
22-Desfluoro-22-chlorofluticasone Dimer Impurity, CAS: /, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₁ClF₄O₈S.
22-Desfluoro-22-iodofluticasone Dimer Impurity, CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₁F₄IO₈S.
5-Iodomethyl 6α,9α-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(3,3,3-d3-propionyloxy)-androsta-1,4-diene-17β-carbothioate, CAS: /, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈D₃F₂IO₅S.
5-Iodomethyl 6α,9α-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(propionyloxy)-androsta-1,4-diene-17β-carbothioate, CAS: 80474-67-5, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁F₂IO₅S.
6α,9-Difluoro-11β-hydroxy-16α-methyl-17-((methylsulfanyl)carbonyl)-3-oxo-androsta-1,4-diene-17α-yl Furoate, CAS: /, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀F₂O₆S.
6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17a-carbothioic Acid, CAS: 80473-92-3, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆F₂O₄S.
6α,9α-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(3,3,3-d3-propionyloxy)-androsta-1,4-diene-17β-carbothioic Acid, CAS: /, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃F₂O₅S.
6α,9α-Difluoro-11β-hydroxy-16α-methyl-3-oxo-17α-(propionyloxy)-androsta-1,4-diene-17β-carbothioic Acid, CAS: 80474-45-9, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀F₂O₅S.
Cloticasone, CAS: 87556-66-9, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇ClF₂O₄S.
Cloticasone Propionate, CAS: 80486-69-7, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁ClF₂O₅S.
Cloticasone Propionate-d3, CAS: /, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈D₃ClF₂O₅S.
Diethoxy Disulfide, CAS: 28752-22-9, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀O₂S₂.
Dimethylthiocarbamoyl Chloride, CAS: 16420-13-6, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆ClNS.
Fluticasone, CAS: 90566-53-3, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇F₃O₄S.
Fluticasone 17β-Carbonylsulfenic Acid 17-Propionate, CAS: 948566-12-9, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀F₂O₆S.
Fluticasone 17β-Carboxylic Acid, CAS: 28416-82-2, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆F₂O₅.
Fluticasone 17β-Carboxylic Acid Propionate, CAS: 65429-42-7, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀F₂O₆.
Fluticasone 17β-Carboxylic Acid Propionate-d3, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃F₂O₆.
Fluticasone Dimer Impurity (~90%), CAS: 220589-37-7, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₁F₅O₈S.
Fluticasone Furoate, CAS: 397864-44-7, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉F₃O₆S.
Fluticasone-d3 17β-Carboxylic Acid, CAS: /, stock: 8.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃F₂O₅.
Fluticasone-d5 Furoate, CAS: /, stock: 8.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄D₅F₃O₆S.
Ioticasone Furoate, CAS: /, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉F₂IO₆S.
Pregna-1,4,9(11),16-tetraene-3,20-dione-9-bromo 11-Formate, CAS: /, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅BrO₄.
Propionyl-3,3,3-d3 Chloride, CAS: 75695-44-2, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₃ClO.
Salmeterol Fluticasone Propionate Mixture, CAS: 136112-01-1, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₆₈F₃NO₉S.
Ticabesone Propionate, CAS: 73205-13-7, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂F₂O₅S.
Trisulfide Acetyl Ethoxy, CAS: 61268-23-3, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂S₃.
(2R)-3-Bromo-2-hydroxy-2-methylpropionic Acid, CAS: 261904-39-6, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₃.
2-Methyl-N-[3-(trifluoromethyl)phenyl]propanamide, CAS: 1939-27-1, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂F₃NO.
4-Nitro-3-(trifluoromethyl)aniline (FLU-1), CAS: 393-11-3, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅F₃N₂O₂.
4’-Nitro-3’-(trifluoromethyl)acetanilide, CAS: 393-12-4, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇F₃N₂O₃.
Flutamide, CAS: 13311-84-7, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁F₃N₂O₃.
Flutamide-d7, CAS: 223143-72-3, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄D₇F₃N₂O₃.
Hydroxy Flutamide, CAS: 52806-53-8, stock: 8.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁F₃N₂O₄.
Hydroxy Flutamide-d6, CAS: 223134-73-4, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₅D₆F₃N₂O₄.
N-(4-Amino-3-(trifluoromethyl)phenyl)acetamide, CAS: 1579-89-1, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₂OF₃.
N-Hydroxy-4-nitro-3-(trifluoromethyl)aniline (FLU-1-N-OH), CAS: 904328-95-6, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅F₃N₂O₃.
N-[4-Amino-3-(trifluoromethyl)phenyl]-2-methylpropanamide (FLU-6), CAS: 39235-51-3, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃F₃N₂O.
N-[4-Nitro-3-(trifluoromethyl)phenyl]-propanamide, CAS: 13312-12-4, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉F₃N₂O₃.
N-[4-Nitro-3-(trifluoromethyl)phenyl]-propanamide-d5, CAS: /, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₅F₃N₂O₃.
o-Flutamide, CAS: 151262-93-0, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁F₃N₂O₃.
o-Flutamide-d7, CAS: /, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄D₇F₃N₂O₃.
(S)-β-Isopropylphenethylamine, CAS: 106498-32-2, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N.
2-(3-Ethylphenyl)acetic Acid, CAS: 89723-25-1, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.
α-Methyl-4-propylphenylacetic Acid, CAS: 3585-47-5, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.
(6α,11β,16α)-6-Fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3,20-dioxo-pregn-4-en-21-oic Acid, CAS: 89945-61-9, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁FO₇.
(6α,11β,16α,17α)-6-Fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3-oxo-androst-4-ene-17-carboxylic Acid, CAS: 75578-60-8, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁FO₆.
11-Keto Flurandrenolide, CAS: 1683-10-9, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁FO₆.
14,15-Dehydro Flurandrenolide, CAS: /, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁FO₆.
Flurandrenolide 21-Aldehyde, CAS: 89945-63-1, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁FO₆.
2-Amino-6-(benzylamino)-3-nitropyridine, CAS: 21626-43-7, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₄O₂.
2-Amino-6-[(4-fluorobenzyl)-amino]-3-nitropyridine, CAS: 33400-49-6, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁FN₄O₂.
2-Amino-6-[(4-fluorobenzyl)-amino]-3-nitropyridine-d4, CAS: 1330170-09-6, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₄FN₄O₂.
5-[[(4-Fluorophenyl)methyl]amino]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one, CAS: 951624-49-0, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁FN₄O.
5-[[(4-Fluorophenyl)methyl]amino]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one-d4, CAS: 1346598-41-1, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇D₄FN₄O.
6-Amino-2-(4-fluorobenzyl)amino-3-nitro-pyridine, CAS: 1506942-35-3, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁FN₄O₂.
6-Chloro-N-[(4-fluorophenyl)methyl]-3-nitro-2-pyridinamine, CAS: 905586-93-8, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉ClFN₃O₂.
D 13223 (Flupirtine Metabolite), CAS: 95777-69-8, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆ClFN₄O.
D 13223-d4 (Flupirtine Metabolite), CAS: 1216989-17-1, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₄ClFN₄O.
D13223 N6-β-D-Glucuronide, CAS: 1147289-78-8, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₄O₇.
D13223-N2-β-D-Glucuronide, CAS: 1147289-76-6, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃FN₄O₇.
Dehydro-D 13223 (Flupirtine Metabolite), CAS: /, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃FN₄O.
Desfluoro Flupirtine Hydrochloride, CAS: 21630-56-8, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉ClN₄O₂.
Ethyl 2,6-Bis(4-fluorobenzylamino)-pyridin-3-carbamate, CAS: /, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃ClF₂N₄O₂.
Flupirtine 2-Ethyl Carbamate Hydrochloride, CAS: /, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂ClFN₄O₄.
Flupirtine Maleate, CAS: 75507-68-5, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁FN₄O₆.
Flupirtine-d4 Hydrochloride Salt, CAS: 1324717-75-0, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₄ClFN₄O₂.
Flupirtine-d5, CAS: 56995-20-1, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₅FN₄O₂.
Flupirtine-N2-β-D-Glucuronide, CAS: 1147289-74-4, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅FN₄O₈.
Flupirtine-N6-β-D-Glucuronide, CAS: 1147289-72-2, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅FN₄O₈.
N’N-2,6-Bis(4-fluorobenzyl)-3-nitro-pyridine-2,6-diamine, CAS: /, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆F₂N₄O₂.
(E/Z)-Flupentixol Dihydrochloride, CAS: 2413-38-9, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂F₃N₂OS.
(E/Z)-Flupentixol-d4 Dihydrochloride, CAS: /, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₄Cl₂F₃N₂OS.
1,1-Dimethylethyl 4-(2-Hydroxyethyl)piperazine-1-carboxylate-d4, CAS: 1219802-10-4, stock: 6.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈D₄N₂O₃.
2-Trifluoromethylthioxanthone, CAS: 1693-28-3, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇F₃OS.
cis-(Z)-Flupentixol Bromide, Dihydrobromide, CAS: /, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆Br₃F₃N₂S.
cis-(Z)-Flupentixol Dihydrochloride, CAS: 51529-01-2, stock: 9.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂F₃N₂OS.
cis-(Z)-Flupentixol Methanethiosulfonate, CAS: /, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇F₃N₂O₂S₃.
Dihydro Flupentixol, CAS: 14141-25-4, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇F₃N₂OS.
Dihydro Flupentixol-d4, CAS: 1795025-21-6, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₄F₃N₂OS.
N-(2-Hydroxyethyl)piperazine-d4 Dihydrochloride, CAS: 1160357-16-3, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂D₄Cl₂N₂O.
O-(2-Hydroxyethyl) Flupentixol Dihydrochloride, CAS: 1535-17-7, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉F₃N₂O₂S • 2(HCl).
O-(2-Hydroxyethyl) Flupentixol-d4 Dihydrochloride, CAS: 1795137-01-7, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₄Cl₂F₃N₂O₂S.
trans-(E)-Flupentixol Bromide, Dihydrobromide, CAS: /, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆Br₃F₃N₂S.
trans-(E)-Flupentixol Dihydrochloride, CAS: 51529-02-3, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇Cl₂F₃N₂OS.
trans-(E)-Flupentixol Methanethiosulfonate, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇F₃N₂O₂S₃.
(3-Phenylpropyl)carbamic Acid Ethyl Ester, CAS: 185910-72-9, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.
(3R)-Meta Fluoxetine Hydrochloride, CAS: /, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈F₃NO.(HCl).
(3S)-Meta Fluoxetine Hydrochloride, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈F₃NO.(HCl).
(αR)-α-(Iodomethyl)-3,4-dimethoxybenzenemethanol, CAS: 833353-17-6, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃IO₃.
(R)-(+)-3-Chloro-1-phenyl-1-propanol, CAS: 100306-33-0, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁ClO.
(R)-De(trifluoromethyl) Fluoxetine Hydrochloride, CAS: 1212215-97-8, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClNO.
(R)-Fluoxetine Hydrochloride, CAS: 114247-09-5, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClF₃NO.
(R)-Fluoxetine-d5 Hydrochloride, CAS: 1217764-54-9, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₅ClF₃NO.
(R)-Norfluoxetine, CAS: 130194-43-3, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆F₃NO.
(R)-Norfluoxetine Phthalimide, CAS: 878663-12-8, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈F₃NO₃.
(R)-Norfluoxetine-d5(Phenyl-d5), CAS: 1217648-64-0, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₅F₃NO.
(R)-Norfluoxetine-d5 Phthalimide(Phenyl-d5), CAS: 1346617-46-6, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₃D₅F₃NO₃.
(S)-Fluoxetine Hydrochloride, CAS: 114247-06-2, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClF₃NO.
(S)-Fluoxetine-d5 Hydrochloride, CAS: 1217680-98-2, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₅ClF₃NO.
(S)-Norfluoxetine, CAS: 126924-38-7, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆F₃NO.
(S)-Norfluoxetine Phthalimide, CAS: 878663-13-9, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈F₃NO₃.
(S)-Norfluoxetine-d5(Phenyl-d5), CAS: 1217770-71-2, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₅F₃NO.
(S)-Norfluoxetine-d5 Phthalimide(Phenyl-d5), CAS: 1795786-54-7, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₃D₅F₃NO₃.
3-Chloropropiophenone, CAS: 936-59-4, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO.
3-[Benzyl(methyl)amino]-1-phenylpropan-1-ol, CAS: 74681-55-3, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO.
Desamino Chloro (R)-Fluoxetine, CAS: 1346617-29-5, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉D₅ClF₃O.
Desamino Chloro (S)-Fluoxetine, CAS: 114446-51-4, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄ClF₃O.
Fluoxetine, CAS: 54910-89-3, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈F₃NO.
Fluoxetine (1.0 mg/mL in Methanol), CAS: 54910-89-3, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈F₃NO.
Fluoxetine Hydrochloride, CAS: 56296-78-7, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClF₃NO.
Fluoxetine N-β-D-Glucuronide, CAS: 96735-71-6, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅F₃NNaO₇.
Fluoxetine-d5 Hydrochloride, CAS: 1173020-43-3, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄D₅ClF₃NO.
Fluoxetine-d5 solution, CAS: 1173147-79-9, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₅F₃NO.
Fluoxetine-d6 Oxalate (0.1 mg/mL in Methanol), CAS: /, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₆F₃NO  •  C₂H₂O₄.
Meta Fluoxetine Hydrochloride, CAS: 79088-29-2, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClF₃NO.
Meta Fluoxetine-d3 Hydrochloride, CAS: /, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₃ClF₃NO.
N-(Methyl-d3)-3-phenylpropylamine, CAS: 55469-88-0, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₃N.
N-Formylfluoxetine, CAS: 199188-97-1, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈F₃NO₂.
N-Methyl Fluoxetine Hydrochloride, CAS: 885101-12-2, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁ClF₃NO.
N-Methyl Meta Fluoxetine Hydrochloride, CAS: /, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁ClF₃NO.
N-Methyl-3-phenylpropylamine, CAS: 23580-89-4, stock: 2.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N.
Norfluoxetine Hydrochloride, CAS: 57226-68-3, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClF₃NO.
Norfluoxetine N-β-D-Glucuronide, CAS: 96735-72-7, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄F₃NO₇.
Norfluoxetine-d5 Hydrochloride (Phenyl-d5), CAS: 1188265-34-0, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₅ClF₃NO.
Norfluoxetine-d5 Hydrochloride, CAS: 1185132-92-6, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₅ClF₃NO.
p-Nitrobenzal Difluoride, CAS: 29848-57-5, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅F₂NO₂.
Cicletanine Hydrochloride, CAS: 82747-56-6, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃Cl₂NO₂.
Cicletanine-d4 Hydrochloride, CAS: 1189491-41-5, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₄Cl₂NO₂.
Furosemide Acyl-β-D-glucuronide, CAS: 72967-59-0, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClN₂O₁₁S.
Furosemide Acyl-β-D-glucuronide Allyl Ester, CAS: 72967-59-0, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClN₂O₁₁S.
Tetrahydro Furosemide, CAS: 4793-38-8, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅ClN₂O₅S.
1,3-Bis(4-methoxybenzyl)-5-fluorouracil, CAS: 897304-05-1, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉FN₂O₄.
1,3-Di(benzyloxymethyl)-5-fluorouracil, CAS: 75500-03-7, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉FN₂O₄.
1,3-Dibenzyl-5-fluorouracil, CAS: 75500-02-6, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅FN₂O₂.
2,4,6-Piperidinetrione Sodium Salt, CAS: 1135049-14-7, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄NNaO₃.
2-Aminopropane-1,3-diol, CAS: 534-03-2, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉NO₂.
2-Bromo-1,3-difluoropropane, CAS: 03/05/2195, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅BrF₂.
2-chloro-6-hydroxy-4(3H)-Pyrimidinone, CAS: 1216965-68-2, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃ClN₂O₂.
3-Cyano-6-hydroxypyridone Sodium Salt, CAS: 91467-46-8, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃N₂NaO₂.
5-(Propargyloxy)-2’-deoxyuridine, CAS: 65367-85-3, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₆.
5-Chlorouracil, CAS: 1820-81-1, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃ClN₂O₂.
5-Ethyl-2’-deoxyuridine, CAS: 15176-29-1, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₅.
5-Ethyl-2’-deoxyuridine-d5, CAS: /, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₅N₂O₅.
5-Fluoro-6-hydroxyhydro Uracil(Mixture of Diastereomers), CAS: 37103-91-6, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅FN₂O₃.
5-Fluorodihydro-1,3-bis[(4-methoxyphenyl)methyl]pyrimidine-2,4-dione-13C,15N2, CAS: /, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³CH₂₁F¹⁵N₂O₄.
5-Fluorodihydropyrimidine-2,4-dione, CAS: 696-06-0, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅FN₂O₂.
5-Fluorodihydropyrimidine-2,4-dione-13C,15N2, CAS: 1189492-99-6, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₅F¹⁵N₂O₂.
5-Fluorouracil N-β-D-Glucuronide, CAS: 66048-45-1, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FN₂O₈.
5-Fluorouracil N-β-D-Glucuronide Methyl Ester, 2,3,4-Triacetate, CAS: 77476-81-4, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉FN₂O₁₁.
5-Fluorouracil-13C,15N2 N-β-D-Glucuronide, CAS: /, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₁F¹⁵N₂O₈.
5-Fluorouridine 5’-Triphosphate, CAS: 3828-96-4, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄FN₂O₁₅P₃.
5-Methoxyuracil, CAS: 6623-81-0, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O₃.
6-Hydroxy-2(1H)-pyridinone Hydrochloride, CAS: 10357-84-3, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClNO₂.
Carmofur, CAS: 61422-45-5, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆FN₃O₃.
Carmofur-d11, CAS: /, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₅D₁₁FN₃O₃.
CPT 11, CAS: 100286-90-6, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₄O₆.HCl.
Ethoxy-5-fluoro-4(3H)-pyrimidinone, CAS: 56177-80-1, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇FN₂O₂.
Isobarbituric Acid, CAS: 496-76-4, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄N₂O₃.
Tegafur, CAS: 17902-23-7, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈FN₂O₃.
Tegafur-13C,15N2, CAS: 1189456-27-6, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₉F¹⁵N₂O₃.
Tegafur-d7, CAS: /, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂D₇FN₂O₃.
Urea, CAS: 57-13-6, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₄N₂O.
1-(2-Chloroacetyl)-5-fluoropyrimidine-2,4(1H,3H)-dione, CAS: 110073-43-3, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₃FCl.
2,4-Dibromo-5-fluoropyrimidine, CAS: 1372096-33-7, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HBr₂FN₂.
2,4-Difluoropyrimidine, CAS: 2802-61-1, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂F₂.
2-(Bromomethyl)-5-fluoropyrimidine, CAS: 1227579-62-5, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂FBr.
2-Amino-4-trifluoropyrimidine-5-boronic Acid Pinacol Ester, CAS: 944401-58-5, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BF₃N₃O₂.
2-Amino-5-fluoropyrimidine, CAS: 1683-85-8, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄FN₃.
2-Bromo-5-fluoropyrimidine, CAS: 947533-45-1, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂BrFN₂.
2-Chloro-5-fluoropyrimidine, CAS: 62802-42-0, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂ClFN₂.
2-Fluoropyrimidine, CAS: 31575-35-6, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃FN₂.
4,5,6-Trifluoropyrimidine, CAS: 17573-78-3, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HF₃N₂.
4,6-Dichloro-2-ethyl-5-fluoropyrimidine, CAS: 1152109-89-1, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂FCl₂.
4,6-Dichloro-5-fluoropyrimidine, CAS: 213265-83-9, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HCl₂FN₂.
4,6-Difluoropyrimidine, CAS: 2802-62-2, stock: 3.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂N₂F₂.
4-Amino-2-chloro-5-fluoropyrimidine, CAS: 155-10-2, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃FCl.
4-Amino-6-chloro-5-fluoropyrimidine, CAS: 851984-15-1, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₃FCl.
4-Chloro-5-fluoropyrimidine, CAS: 347418-42-2, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂ClFN₂.
4-Chloro-6-ethyl-5-fluoropyrimidine, CAS: 137234-74-3, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆ClFN₂.
4-Ethyl-5-fluoropyrimidine, CAS: 137234-88-9, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇FN₂.
4-Ethyl-5-fluoropyrimidine Hydrochloride, CAS: 1391052-89-3, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈ClFN₂.
4-Ethyl-5-fluoropyrimidine-d3, CAS: 1794786-17-6, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₃FN₂.
5-Bromo-2-fluoropyrimidine, CAS: 62802-38-4, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂BrFN₂.
5-Chloro-2,4,6-trifluoropyrimidine, CAS: 697-83-6, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄ClF₃N₂.
5-Chloro-2,4-difluoropyrimidine, CAS: 25151-07-9, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HClF₂N₂.
5-Fluoro Cytidine, CAS: 2341-22-2, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂FN₃O₅.
5-Fluoro-2,4-dichloropyrimidine, CAS: 2927-71-1, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HCl₂FN₂.
5-Fluoro-2,4-dichloropyrimidine-d1, CAS: /, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄DCl₂FN₂.
5-Fluoro-4-hydroxypyrimidine, CAS: 671-35-2, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃FN₂O.
5-Fluoropyrimidine-2-carboxylic Acid, CAS: 1196151-51-5, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃N₂O₂F.
5-Fluoropyrimidine-4,6-diol, CAS: 106615-61-6, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃N₂O₂F.
5-Fluorouracil-13C,15N2, CAS: 1189423-58-2, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₃F¹⁵N₂O₂.
5-Fluorouracil-6-d1, CAS: 90344-84-6, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂DFN₂O₂.
5’-O-(Dimethoxytrityl)-5-fluoro-2’-O-methyluridine, CAS: 869355-45-3, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁FN₂O₈.
cis-5-Fluoro-1-[2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione, CAS: 1217659-69-2, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃FN₂O₄SSi.
cis-5-Fluoro-1-[2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione-13C,15N2, CAS: 1217650-77-5, stock: 5.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³CH₂₃F¹⁵N₂O₄SSi.
Dihydroxyvoriconazole, CAS: 1253968-73-8, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄F₃N₅O₃.
Fluorocytidine Triphosphate Tetraammonium Salt, CAS: /, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₀FN₄O₁₄P₃.
Methyl 5-Fluoropyrimidine-2-carboxylate, CAS: 1227575-47-4, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂F.
(6α,11β,16α)-21-(Acetyloxy)-9-bromo-6-fluoro-11-hydroxy-16-methyl-pregna-1,4-diene-3,20-dione, CAS: 54604-73-8, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀BrFO₅.
(6α,9β,11β,16α)-21-(Acetyloxy)-9,11-epoxy-6-fluoro-16-methyl-d3-pregna-1,4-diene-3,20-dione, CAS: /, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆D₃FO₅.
(6α,9β,11β,16α)-21-(Acetyloxy)-9,11-epoxy-6-fluoro-16-methyl-pregna-1,4-diene-3,20-dione, CAS: 61618-91-5, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉FO₅.
17β-Carboxy-17-desoxy Dexamethasone, CAS: 75262-69-0, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇FO₄.
21-Dehydro Fluocortolone, CAS: 53733-52-1, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇FO₄.
Diflucortolone 21-Valerate, CAS: 59198-70-8, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆F₂O₅.
Fluocortolone 21-Hexanoate, CAS: 303-40-2, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉FO₅.
Fluocortolone Acetate, CAS: 1176-82-5, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁FO₄.
Fluocortolone Pivalate, CAS: 29205-06-9, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇FO₅.
Fluocortolone-d3 Pivalate, CAS: /, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄D₃FO₅.
(((9H-Fluorene-9,9-diyl)bis(4,1-phenylene))bis(oxy))bis(ethane-2,1-diyl) Diacrylate, CAS: 161182-73-6, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀O₆.
(2,5-Dimethylphenyl)boronic Acid, CAS: 85199-06-0, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁BO₂.
(2-​Bromo-​6-​methoxyphenyl)​phenyl-​methanone, CAS: /, stock: 10g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁BrO₂.
(9,9-Dimethyl-9h-fluorene-2,7-diboronic acid, CAS: 866100-14-3, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆B₂O₄.
(9E)-Lumefantrine, CAS: 1456736-33-6, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂Cl₃NO.
(E,Z)-9-(4-Chlorophenyl)methylene-5-oxiranyl-2,7-dichlorofluorene, CAS: 252990-29-7, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃Cl₃O.
(S)-N-Fmoc-L-norleucine-13C6,15N, CAS: 1346617-52-4, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³C₆H₂₃¹⁵NO₄.
(Z)-Desbutyl Lumefantrine, CAS: 355841-11-1, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄Cl₃NO.
1,2-Benzo-9-thiafluorene, CAS: 239-35-0, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀S.
1,2-Benzofluorene, CAS: 238-84-6, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂.
1,3,2-Dioxaborolane, 2,2’-(9,9-dimethyl-9h-fluorene-2,7-diyl)bis[4,4,5,5-tetramethyl], CAS: 325129-69-9, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆B₂O₄.
1,3,6,8-Tetrabromopyrene, CAS: 128-63-2, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₆Br₄.
1,7-Dimethyl-9H-fluoren-9-one, CAS: 441-97-4, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O.
1,7-Dimethylfluorene, CAS: 442-66-0, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄.
1-Fluorenecarboxylic Acid, CAS: 05/03/6276, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂.
1-Hydroxy-9H-fluoren-9-one, CAS: 6344-60-1, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂.
1-Methoxy-9H-fluoren-9-one, CAS: 42523-15-9, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂.
1-Methylfluorene, CAS: 1730-37-6, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂.
2,2’,7,7’-Tetrabromo-9,9’-bifluoroenylidene, CAS: 27192-91-2, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₂Br₄.
2,2’,7,7’-Tetrabromo-9,9’-spirobifluorene, CAS: 128055-74-3, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₂Br₄.
2,2’,7,7’-Tetrakis-(N,N-di-4-methoxyphenylamino)-9,9’-spirobifluorene, CAS: 207739-72-8, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₁H₆₈N₄O₈.
2,2’-(((9H-Fluorene-9,9-diyl)bis(4,1-phenylene))bis(oxy))diethanol, CAS: 117344-32-8, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆O₄.
2,2’-(6,6,12,12-Tetraoctyl-6,12-dihydroindeno[1,2-b]fluorene-2,8-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), CAS: 628303-20-8, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₄H₁₀₀B₂O₄.
2,2’-Dibromo-9,9’-spirobi[fluorene], CAS: 67665-47-8, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₄Br₂.
2,2’’,4’,5,5’’-Pentamethyl-1,1’:2’,1’’-terphenyl, CAS: /, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄.
2,3-Benzofluorene, CAS: 243-17-4, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂.
2,4,7-Trichlorofluorene, CAS: 7061-81-6, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₇Cl₃.
2,5-Bis(4-bromophenyl)-1,1-dimethyl-3,4-diphenylsilole, CAS: 866769-99-5, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₄Br₂Si.
2,5-Dichlorofluorene, CAS: 934748-28-4, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈Cl₂.
2,5-Dinitrofluorene, CAS: 15110-74-4, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈N₂O₄.
2,7-Bis[N,N-bis(4-methoxyphenyl)amino]9,9-spiro-bifluorene, CAS: 1138220-69-5, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₄₂N₂O₄.
2,7-Bis[N-(m-tolyl)anilino]-9,9’-spirobi[9H-fluorene], CAS: 1033035-83-4, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₃₈N₂.
2,7-Di(acetamido)fluorene, CAS: 304-28-9, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₂.
2,7-Di-tert-butylfluorene, CAS: 58775-05-6, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆.
2,7-Diacetylfluorene, CAS: 961-27-3, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O₂.
2,7-Diaminofluorene, CAS: 525-64-4, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂.
2,7-Diaminofluorene Dihydrochloride, CAS: 13548-69-1, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂ • 2(HCl).
2,7-Dibromo-2’,3’,5’,6’-tetrahydrospiro[fluorene-9,4’-pyran], CAS: 934269-17-7, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄Br₂O.
2,7-Dibromo-9,9-difluorofluorene, CAS: 1229603-71-7, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆Br₂F₂.
2,7-Dibromo-9,9-dimethylfluorene, CAS: 28320-32-3, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂Br₂.
2,7-Dibromo-9,9-diphenylfluorene, CAS: 186259-63-2, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₆Br₂.
2,7-Dibromo-9,9’-spirobifluorene, CAS: 171408-84-7, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₄Br₂.
2,7-Dibromo-9-heptylcarbazole, CAS: 1173071-58-3, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁Br₂N.
2,7-Dibromo-9H-fluorene, CAS: 16433-88-8, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈Br₂.
2,7-Dichloro-9-[(4-chlorophenyl)methylene]-β-(dibutylamino)-9H-fluorene-4-ethanol (Lumefantrine Impurity A), CAS: 1331642-68-2, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂Cl₃NO.
2,7-Dichlorofluorene, CAS: 7012-16-0, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈Cl₂.
2,7-Diiodo-9,9-dimethylfluorene, CAS: 144981-86-2, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂I₂.
2,7-Diiodofluorene, CAS: 16218-28-3, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈I₂.
2,7-Dimethyl-9H-fluorene, CAS: 2851-80-1, stock: 9.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄.
2,7-Dinitrofluorene, CAS: 5405-53-8, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈N₂O₄.
2-(4-(Dimethylamino)benzylideneamino)fluorene, CAS: 13924-53-3, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂.
2-(9,9’-Spirobi[fluoren]-2-yl)-4,6-diphenyl-1,3,5-triazine, CAS: 1207176-84-8, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₂₅N₃.
2-(Dibutylamino)-1-(2,7-dichloro-9H-fluoren-4-yl)ethanol, CAS: 69759-61-1, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉Cl₂NO.
2-Acetamidofluorene, CAS: 53-96-3, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.
2-Acetyl-7-bromofluorene, CAS: 34172-50-4, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁BrO.
2-Acetylfluorene, CAS: 781-73-7, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O.
2-Amino-7-bromofluorene, CAS: 6638-60-4, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀NBr.
2-Amino-7-nitrofluorene, CAS: 1214-32-0, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₂O₂.
2-Amino-9,9-dimethylfluorene, CAS: 108714-73-4, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.
2-Aminofluorene, CAS: 153-78-6, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N.
2-Bromo-1-chloro-4-methyl-benzene, CAS: 57310-39-1, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrCl.
2-Bromo-6-methoxybenzoyl Chloride, CAS: 1261645-01-5, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BrClO₂.